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SUMMARY 
We aimed to characterize the function of ADP-dependent glucokinase (adpgk), a novel 
glucokinase in the embryonic development of zebrafish. Our study is the first study reporting 
the importance of adpgk in fine-tuning glucose metabolism during the early developmental 
process.  
Knockdown of adpgk in zebrafish embryos significantly induced hexokinase1 expression and 
increased the glucose consumption, indicated by decreased free glucose and increased 
glucose-6-phosphate levels. The adpgk knockdown embryos underwent an adaptive glucose 
metabolism with activated pentose phosphate pathway, exhibiting a reduction in one-carbon 
metabolism and hexosamine biosynthesis pathway. The dysregulated N-glycans synthesis 
further caused malfunctioning of proteins in the developmental signaling pathways which led 
to deformed convergent extension during the embryonic development of zebrafish. In concert 
with the altered glucose homeostasis, the adpgk knockdown embryonic cells endure an acid-
base imbalance and compromised anti-oxidant systems. Furthermore, the metabolic 
disturbance induced the activation of cell cycle checkpoints, indicated by increased cdkn1a 
and gadd45aa expression and apoptosis, which in turn, exacerbated the deformed embryonic 
body patterning.  
Overall, adpgk seems to act as a key regulator of glucose metabolism in the cell and thereby 
plays an important role in the embryonic development of zebrafish  
 
 
 
 
 
 
 
 
 
 
 
 
ZUSAMMENFASSUNG 
In dieser Arbeit wird die Funktion der ADP-abhängigen Glucokinase (adpgk) charakterisiert. 
Hierbei handelt es sich um eine neue Glucokinase in der Embryonalentwicklung des 
Zebrafisch. Wir demonstrieren erstmals die Notwendigkeit der adpgk in der Einstellung des 
Glukosemetabolismus während der frühen Entwicklungsprozesse.  
Der adpgk Knock-down in Zebrafischembryonen führte zu einer signifikanten Induktion der 
hexokinase1 Expression und einem Anstieg des Glukoseverbrauchs, was anhand der 
reduzierten Menge an freier Glukose und einem Anstieg des Glucose-6-Phosphat Levels 
nachgewiesen werden konnte. In den Embryonen erfolgte schließlich eine Anpassung des 
Glukosemetabolismus an die reduzierte Expression von adpgk und zwar durch Aktivierung 
des Pentosephosphatwegs. Nachgewiesen wurde dies durch Reduktion des C1-Stoffwechsels 
und des Hexosaminbiosynthesewegs. Weiterhin resultierte eine durch den Knock-down 
fehlregulierte N-Glykansynthese in defekten Proteinen, welche an Signalwegen, notwendig für 
die Embryonalentwicklung, beteiligt sind. Dies beeinträchtigte schließlich die konvergente 
Extension während der Entwicklung des Zebrafischs. Neben dem veränderten 
Glukosegleichgewicht zeigten die Zellen der adpgk Knock-down Embryonen zusätzlich ein 
Säure-Base Ungleichgewicht sowie ein geschädigtes antioxidatives System. Hinzu kommt, 
dass durch die metabolische Störung die Zellzyklus-Checkpoints aktiviert wurden. Dies wurde 
durch erhöhte Expression von cdkn1a und gadd45aa sowie einem Anstieg der Apoptose 
nachgewiesen, welche wiederum die deformierte Musterung des Embryonalkörpers 
verschlimmerten. 
Zusammenfassend lässt sich sagen, dass adpgk als Schlüsselenzym in der Regulation des 
Glukosemetabolismus der Zelle fungiert und damit eine wichtige Rolle in der 
Embryonalentwicklung des Zebrafisch spielt. 
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1. INTRODUCTION 
1.1 Glucose metabolism  
Glucose metabolism is essential in all living organisms. Hexokinases/glucokinases convert 
glucose to glucose-6-phosphate as the first glycolytic step [1] (Figure1.1). Through glycolysis, 
pyruvate is generated and further converted to acetyl-CoA. Acetyl-CoA participates in the 
tricarboxylic acid (TCA) cycle, which generates and provides precursors for the downstream 
amino acids and fatty acids synthesis [2, 3]. The reduced form of nicotinamide adenine 
dinucleotide (NADH) is the by-product in the TCA cycle and it subsequently enters the 
mitochondrial respirator chain for oxidative phosphorylation (OXPHOS); thereby, generating 
energy. [4] Pyruvate can also be converted to lactate and generate a small amount of energy 
in the process called fermentation (anaerobic glycolysis). High proliferative cells such as 
embryonic cells and tumors cells, albeit in the presence of oxygen, undergo aerobic glycolysis 
for generating lactate and energy, which is recognized as the Warburg effect. [5, 6] Warburg 
effect is originally described by Otto Warburg and the colleagues in the 1920s from the 
observation of increased glucose consumption in the cancer cells. [5] The increased glucose 
uptake and lactate production become the feature of the Warburg effect [4, 7, 8]. 
 
1.2 Pentose phosphate pathway 
In addition to glycolysis, glucose metabolism also includes the pentose phosphate pathway 
(PPP), serine biosynthesis pathway, hexosamine biosynthesis pathway, and glucogenesis. [4, 
9] During PPP, glucose-6-phosphate is converted to ribulose-5-phosphate with the production 
of reduced nicotinamide adenine dinucleotide phosphate (NADPH). NADPH is an important 
molecule of anti-oxidative defense by reducing oxidized glutathione (GSSG) to reduced 
glutathione (GSH) via glutathione reductase. This process detoxifies hydrogen peroxide to 
water and protects cells against reactive oxygen species (ROS)-induced damage. Furthermore, 
ribulose-5-phosphate is converted to ribose-5-phosphate, which provides the precursors for 
ribonucleotides synthesis (DNA and RNA). Ribose-5-phosphate undergoes transaldolation 
and transketolation, and generates fructose-6-phosphate, erythrose-4-phosphate, and 
glyceraldehyde-3-phosphate. [9, 10] The products of PPP contribute to amino acid synthesis, 
and refuel glycolysis and hexosamine biosynthesis pathway. [4, 9-11] 
INTRODUCTION 
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Figure 1.1 Overview of the glucose metabolism. Glucose metabolism provides precursors for 
the synthesis of glycans, amino acids, nucleotides, fatty acids and glycogen.  
Hexokinase (HK); phosphate (P); glutamine:fructose-6-phosphate amidotransferase (GFAT); 
tricarboxylic acid (TCA); uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc); oxidative 
phosphorylation (OXPHOS) 
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1.3 Serine biosynthesis pathway 
Glucose metabolism provides precursors for serine biosynthesis pathway (Figure 1.2). [12] 
Under the catalysis of phosphoglycerate dehydrogenase, phosphoserine aminotransferase 
and phosphoserine phosphatase, 3-phosphoglycerate is converted to serine. In addition, it 
plays a role in nucleotide synthesis and methylation. During the conversion between serine to 
glycine, serine denotes one-carbon unit to tetrahydrofolate cycle, which couples with 
methionine cycle in one-carbon metabolism. [13, 14] Serine derived one-carbon units are then 
utilized for synthesizing adenosine, guanosine and thymidylate. During methionine cycle, S-
adenosylmethionine (SAM) is produced. Through methyltransferase enzymes, SAM donates 
the methyl group for DNA, RNA, proteins and lipids methylation, and produces S-
adenosylhomocysteine (SAH). SAH is subsequently converted to homocysteine which can be 
used for cysteine and glutathione synthesis. In addition to being the methyl group donor, SAM 
also participates in the polyamine biosynthetic pathway with the generation of by-product, 
methylthioadenosine (MTA). [12, 15] 
 
Figure 1.2 Scheme of serine biosynthesis and one-carbon metabolism pathway Glycolysis 
provides resource (3-phosphoglycerate) for serine biosynthesis. The conversion of serine to 
glycine refuels the one-carbon metabolism, the coupling of tetrahydrofolate and methionine 
cycles. The Figure is from Hay, N. Nat Rev Cancer 2016 16: (10) 635-649 [4] 
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1.4 Hexosamine biosynthesis pathway  
Hexosamine biosynthesis pathway regulates posttranslational protein modification by 
generating uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc). It starts with glucose-6-
phosphate and fructose-6-phophate. The subsequent reactions utilize glutamine, acetyl-CoA 
and UDP for UDP-GlcNAc synthesis. UDP-GlcNAc acts as the fundamental building block for 
the biosynthesis of O-GlcNAcylation, N-linked glycosylation, and O-linked glycosylation. [4] 
 
1.4.1 O-GlcNAcylation  
O-GlcNAcylation is the attachment of O-linked N-acetylglucosamine (O-GlcNAc) moieties to 
serine and threonine residues of the proteins. The attachment and removal of O-GlcNAc to 
proteins is catalyzed by only a pair of enzymes, O-GlcNAc transferase (OGT) and O-
GlcNAcase (OGA), respectively. The nucleocytoplasmic and short isoforms of OGT are 
present in the nucleus and cytoplasm. Other isoforms include mitochondrial OGT and ER-
expressed EGF domain specific OGT. UDP-GlcNAc is the product of glucose metabolism; thus, 
O-GlcNAcylation is very sensitive to nutrient and stress stimuli. [16-18] OGT can be recruited 
by specific adaptor proteins to O-GlcNAcylate peroxisome proliferator-activated receptors co-
activator 1α (PCG1α) and pyruvate kinase isoform 2 (PKM2); thereby, regulating 
gluconeogenesis and glycolysis to maintain glucose homeostasis. [19, 20] In addition, nuclear 
OGT can directly regulate the activation and repression of gene transcription by targeting to 
RNA polymerase II [21, 22] and transcription factors including nuclear factor-κB (NF-κB) and 
specificity protein 1 (Sp1) [23-26], and influences epigenetic regulation by targeting to histone-
modifying enzymes. [27-32] Alteration of O-GlcNAcylation can increase or decrease 
phosphorylation.[33] Moreover, O-GlcNAcylation and phosphorylation show mutual exclusivity 
from each other when acting on the same site of the proteins such as RNA polymerase II [21, 
34] and myelocytomatosis oncogene (c-Myc).[35]. Overall, O-GlcNAcylation is a highly 
dynamic protein modification. [17, 36]  
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1.4.2 N-linked glycosylation 
Asparagine (N)-linked glycosylation is the covalent attachment of an oligosaccharide (glycan) 
to the nitrogen atom of asparagine residues in the polypeptide chains. This protein modification 
system is present in all domains of life including Bacteria, Archaea and Eukarya. [37] More 
than half of the eukaryotic proteins have been predicted to be glycoproteins and 90% of them 
most likely carry N-linked glycans. [38] Proteins with N-linked glycosylation serve diverse 
functions. The N-linked glycosylation modification is important in enhancing the protein 
solubility, stabilizing the proteins against proteolysis and degradation, facilitating the 
orientation of the proteins to the membrane and mediating immune responses. [39] The 
biosynthetic pathway of N-glycans (Figure 1.3) is initiated at the cytosolic side of the 
endoplasmic reticulum (ER) membrane. It starts with the binding of nucleotide-activated sugar 
donor (UDP-GlcNAc) to the lipid anchor, dolichylprophosphate, which generates dolichol 
pyrophosphate N-acetylglucosamine (Dol-P-P-GlcNAc). With a series of different specific 
glycosyl transferase, UDP-GlcNAc and guanosine diphosphate-mannose (GDP-Man) serve as 
the substrate for extending Dol-P-P-GlcNAc to Dol-P-P-GlcNAc2Man5. This dolichol-linked 
oligosaccharide is then flipped to the luminal face of the ER membrane where 
dolichylphosphomannose and dolichylphosphoglucose are used as the substrate for 
synthesizing glucose3-mannose9-N-acetylglucosamine2 (Glc3Man9GlcNAc2). 
Oligosaccharyltransferase then catalyses the en bloc transfer of Glc3Man9GlcNAc2 to the 
nascent polypeptide chains containing the consensus sequence (N-X-S/T). [37, 40-42] 
Subsequently, the polypeptide-bound Glc3Man9GlcNAc2 is trimmed and modified in the ER. 
Glucosidase I and II remove the outtermost α1–2-bound glucose and the inner α1–3 glucose, 
respectively. Glc1Man9GlcNAc2 associates with lectin chaperones calnexin and calreticulin, 
recruiting the lectin-associated oxidoreductase ERp57 for folding polypeptides. [43, 44] After 
being released from calnexin/calreticulin/ERp57, glucosidase II removes another glucose 
residue (Man9GlcNAc2) to prevent its re-association. [45] Before exiting the ER, an ER 
degradation-enhancing α-mannosidase I–like protein (EDEM) can recognize and target the 
misfolded glycoproteins for degradation. The trimming and modification of the glycans continue 
in the Golgi by N-acetylglucosaminyltransferases and mannosidases, which generates hybrid 
and complex N-glycans. Moreover, the hybrid and complex N-glycans become mature N-
glycans by elongating the GlcNac branching and adding sugar to the core and the branch such 
as sialic acid, fucose and galactose. [37, 40] After the trimming, processing and modification 
in ER and Golgi, the N-linked glycoproteins were secreted. [39]  
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Figure 1.3 Schematic representation of biosynthesis of N-glycosylation. UDP-GlcNAc, the 
product of hexosamine biosynthesis pathway, binds to the lipid anchor of the ER membrane 
and acts as the building block of N-glycans. The glycans are further extended with mannose 
and trimmed in the ER. Subsequently, the high mannose glycas are extended with other sugars 
and modified in the Golgi; furthermore, forming the complex- and hybrid-type glycans. 
The Figure is modified from Vasconcelos-dos-Santos, A. et al. Frontiers in Oncology, 2015.  
5(138) [46] 
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1.5 ADP-dependent glucokinase (ADPGK) 
ADP-dependent glucokinase (EC 2.7.1.147) utilizes ADP as the phosphoryl donor to catalyze 
the reaction of glucose to glucose-6-phosphate. It was first identified in Archaea involved in 
glucose breakdown in a modified Embden-Meyerhof glycolytic pathway. [47] Richter, S. et al. 
has determined the structure of mammalian ADPGK and identified its ribokinase-like tertiary 
fold, which is similar to archaeal orthologues. In contrast to archaeal adpgks that can utilize 
other nucleotide diphosphates as the phosphoryl donor, human ADPGK shows high specificity 
for ADP. [48] In addition, ADPGK has high substrate specificity for glucose and accepts no 
other sugars including 2-deoxyglucose as substrates. The activity of ADPGK is inhibited by 
high concentration of glucose and AMP, while hexokinase I to IV are inhibited by their product, 
glucose-6-phosphate. [49] Human ADPGK exhibits Km for glucose at 0.48 (±0.09) mm, and Ki 
for glucose and AMP inhibition at 2.9 (±0.6) mm and 0.5 (±0.07) mm, respectively. [48] ADPGK 
has bimodal optimal pH at around 5.75 to 6.5 and 8.75 to 9.0 [49], and the optimal temperature 
is at 42o [50].  
Human ADPGK is located at chromosome 15 (15q24.1). It is localized in the ER and expressed 
in various normal and tumor tissues with high expression in the immune cells and bone marrow, 
and in leukemia. [51, 52] The precise function of eukaryotic ADPGK is still poorly understood. 
It has been shown that ADPGK is activated in the phorbol 12-myristate 13-acetate (PMA)-
stimulated Jurkat cells. [50] The T cell receptor-triggered induction of ADPGK modulates the 
downstream oxidative signals and the NF-κB-dependent gene expression including IL-2 and 
IL-8. [50, 53, 54] In the PMA-stimulated T cells, the ADPGK-driven alteration of the glucose 
metabolism coincides with the deviation of glycolytic flux to the mitochondrial glycerol-3-
phosphate dehydrogenase shuttle. [50] In addition, it has once been postulated that ADPGK 
has a role in anaerobic glycolysis by using ADP as the phosphate donor to save ATP in hypoxic 
cells. However, the results from ADPGK knockout lung cancer cell (H460) and colon cancer 
cells (HCT116) show that ADPGK is not activated by hypoxia-inducible factor 1 (HIF-1) and 
not regulated by hypoxia and anoxia. Interestingly, the genomics study identifies almost half 
of the top 150 genes related to ADPGK knockout encode proteins that can be glycosylated, 
suggesting ADPGK may play a role in glycosylation. [55] Given the high expression of ADPGK 
in high proliferative cells, we sought its functions in embryonic cells using the zebrafish model. 
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1.6 Zebrafish model 
Zebrafish (Danio rerio) belong to the family of cyprinids (Cyprinidae) in the class of ray finned 
fish (Actinopterygii) and are originally from Indian rivers. This small aquatic vertebrate has 
become an excellent model organism for biomedical research especially in the field of 
developmental biology, metabolism, pharmacology and neuroscience. [56, 57] Zebrafish have 
average 4- to 5-year life span and remain sexually active almost all of this period. [58] A single 
female zebrafish can lay several hundred eggs per week and the development of the embryos 
is very rapid. The embryos take only 48 hours to develop through the stages of zygote, 
cleavage, blastula, gastrulation, segmentation, pharyngula to hatching when the primary organ 
synthesis is finished. [59] Unlike mammals, zebrafish develop ex utero and in transparent 
embryos, which enables easy visual observation for organ development and in vivo live-cell 
imaging, and easy accessibility for experimental manipulations such as gene or drug injection. 
Zebrafish possess 25 pair of chromosomes which contain 26,206 protein coding genes. The 
genetic homology of zebrafish is relatively high to humans with approximately 70% of zebrafish 
genes possessing at least one human orthologue and 82% of human genes related to diseases 
having zebrafish counterparts. [60, 61]  
 
1.7 Zebrafish embryonic development  
Upon fertilization, the non-yolky cytoplasm starts to stream to the animal pole and form the 
blastodisc. The segregation of the blastodisc from yolk vegetal cytoplasm continues during the 
cleavage stages. When cells have divided and reached the 512-cell stage (2.75 hpf), the 
embryos enter mid-blastula transition and the yolk syncytial layer forms. [59, 62] During mid-
blastula transition, the developmental control is transferred from maternal to zygotic genes. 
[62] In the late blastula stage, epiboly starts and the cells intercalate radically to thin and spread 
the blastoderm over the yolk. During the gastrulation period, the collective cell involution, 
convergence and extension occur, leading to the formation of hypoblast, primary germ layers 
and embryonic axis. Convergence is the collective cell migration and intercalation from lateral 
and ventral area of the blastoderm to the dorsal side of the embryos; furthermore, forming the 
shield, a thickening region that is equivalent to the amphibian Spemann-Mangold organizer. 
[59, 62] Concomitantly, the converging and intercalated cells spread along the animal-ventral 
axis and form the anterior-posterior axis. [63] At the end of the gastrulation stage, the tail bud 
becomes prominent and the prechordal plate hypoblast accumulates to form a prominent bulge, 
known as polster. As the tail extends, the segmentation starts and the embryo length increases 
rapidly. Kupffer's vesicle forms at 5-somite stage which is the organizer for the establishment 
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of the left-right asymmetric patterning. Subsequently, through the pharyngula to hatching 
periods, the organs start forming and developing. [59, 62-64] 
 
1.8 Early developmental signaling pathways 
The coordination of the main signaling pathways Hedgehog (Hh), Wingless (Wnt), Notch, 
Transforming growth factor β (TGF-β), fibroblast growth factor (FGF) and Bone morphogenic 
proteins (bmp) signaling define cell fate and control embryonic morphogenesis. [62] 
 
1.8.1 Dorsal-ventral axis control 
During zebrafish embryonic development, the dorsal-ventral (back to belly) patterning is 
determined by the maternal factors such as β-catenin. (Figure 1.4) In the canonical wnt 
signaling pathway, the binding of Wnt to Frizzled (Fz) recruits lipoprotein receptor-related 
protein (LRP5/6), Dishevelled (Dsh) and axin, which prevents the degradation and promotes 
the translocation of β-catenin to the nuclei. [65, 66]  β-catenin accumulates specifically in the 
dorsal region of the blastomeres and regulates the gene expression for inhibiting ventralizing 
factors and furthermore, inducing the mesoendodermal fate at the dorsal region. [62, 67, 68] 
In turns, the gradient of the Nodal and FGF-related signaling molecules is generated, which 
induces the patterning of mesoderm. [69, 70] During gastrulation, the embryonic shield 
becomes apparent in the dorsal mesoderm and generates organizer genes including chordin 
and noggin to inhibit Bmp signals, the ventral fate-determinator. Overall, the coordination of 
the Wnt, FGF Nodal, and Bmp signaling pathways determines proper development of dorsal-
ventral axis. [71] 
 
 
 
Figure 1.4 Scheme of the molecular regulation in the dorsal-ventral patterning. Nuclear β-
catenin is specifically accumulated in the dorsal region of the blastomere, which inhibiting the 
ventralizing factor, generating the signaling gradients and promoting the mesoendodermal fate.  
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1.8.2 Convergent extension control 
Convergent extension narrows the embryonic tissues mediolaterally and extends them 
anterioposteriorly. (Figure 1.5) Signaling pathways including β-catenin-Stat3-Liv1-Snail1, 
platelet-derived growth factor (PDGF)/phosphatidylinositol 3-kinase (PI3K), and noncononical 
wnt regulate the convergent and extension cell movement. [63, 72-74] The noncanonical 
wnt/planar cell polarity (PCP) signaling pathway (Figure 1.5) is β-catenin independent. [65] 
The binding of Wnt to Fz recruits Dsh, which activates the small GTPase family proteins. The 
small GTPase family proteins including Rac1 and Rho subsequently regulate the cytoskeleton 
modification during the cell movement. [75] Studies have shown that the molecules of 
noncanonical Wnt signaling including Wnt5 [76], Wnt11 [77], Fz2 [78] and Glypican4 [79] 
regulate convergent and extension. In addition, the ventral expression of Wnt/PCP 
components is regulated by bmp signals; therefore, the cross-talk between signaling pathways 
orchestrate the convergent extension and body patterning. [80] 
 
Figure 1.5 Scheme of convergent extension during zebrafish development. Convergent 
extension during gastrulation stage determines the embryonic body length. Convergent 
extension is the collective cell movement which narrows the embryonic tissues mediolaterally 
and extends them anterioposteriorly. The figure is modified from Tada, M., et al. Development 
139, 3897-3904; 2012 [63] 
 
1.8.3 Left-right asymmetry control 
The determination of left-right asymmetry is another hallmark of the embryonic development. 
Under the regulation of Nodal, FGF, Wnt, Hh and Notch signaling, dorsal surface epithelial 
cells develop into dorsal forerunner cells. The dorsal forerunner cells migrate collectively and 
form the Kupffer’s vesicle, a fluid-filled organ[64]. The counterclockwise fluid flow generated 
by motile cilia rotation in Kupffer’s vesicle promotes the accumulation of the intracellular Ca2+ 
and determines the asymmetric expression of spaw on the left side of Kupffer’s vesicle. Spaw 
initiates a genetic cascade that transfers the directional LR asymmetric information to lateral 
plate mesoderm and further to organ primordia. [64, 80-83] 
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1.9 Cell cycle  
The coordination of cell migration, differentiation and proliferation during embryonic 
development is important. From many aspects, cell cycle is integrated in regulating these 
processes. During early zebrafish embryonic development, cells divide synchronously and the 
cell cycle oscillates rapidly between synthesis (S) and mitosis (M) phase without the 
intervention of Gap (G1 and G2) phase. [59]. After the midblastula transition (approximately 3 
hour post fertilization), cells lose the division synchrony, and the cell cycle length increases 
with the intervention of G1 and G2 phase. [84, 85] Exposing zebrafish embryos to cell cycle 
inhibitors induces apoptosis, indicating zebrafish embryonic cells also possess cell cycle 
checkpoints. [86-89] 
Cell cycle is regulated by cyclin-dependenet kinases (CDKs) and their cyclin partners (Figure 
1.6). Upon receiving the signals from mitogenic factors such as epidermal growth factor, 
CDK4/6 forms a complex with cyclin D, which sequesters the CDK inhibitors including p21CIP1 
(cdkn1a) and p27KIP1, and phosphorylates retinoblastoma (Rb). [90, 91] The phosphorylated 
Rb1 enables E2F to activate the transcription of genes involved in G1-S phase cell cycle 
progression and DNA replications. E2F activates the transcription of cyclin E1 and E2. Cyclin 
E-CDK2 complexes further phosphorylate Rb; thus, creating a positive feedback-loop. In 
addition to cyclin-CDK complexes, other proteins such as polo-like kinase 1 and aurora kinases 
also control the cell cycle progression. [92] The entry of each cell-cycle phase is highly 
controlled at the cell-cycle checkpoints. It occurs at the late G1 phase and late G2 phase, 
which prevents the entry to S phase and M phase, respectively. DNA damage triggers cell 
cycle arrest via checkpoint kinase 1 and 2, and p53. [93, 94] The cell cycle checkpoints allow 
cells to enter to the next phase when it is assured that the previous phase has been 
successfully accomplished and the cell damage has been repaired. Cells failing to repair the 
damage undergo quiescence and/or cell death. [95]  
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Figure 1.6 Molecular regulation of cell cycle. The cell cycle starts when receiving the signals 
from mitogens or growth factors. CDK4/6 subsequently forms a complex with cyclin D 
phosphorylates retinoblastoma (Rb), enabling E protein (E2F) to initiate the transcription of 
genes requiring for the cell cycle progression.  The figure is modified from Aguilar, V., et 
al.EMBO Molecular Medicine (2010) 2, 338-348 [96] 
 
1.10 Apoptosis 
Apoptosis is a programmed cell death with the feature of cell shrinkage, blebbing, DNA 
fragmentation, chromatin condensation, and nuclear and cytoskeletal proteins decaying. [97] 
The central apoptotic pathways are highly conserved within vertebrates. Zebrafish possess all 
the core components of the intrinsic and extrinsic apoptosis pathways that are also functionally 
equivalent to mammals. [98-100] The apoptotic machinery is important in embryonic 
development for maintaining and shaping the morphogenesis. Dysregulation of apoptosis 
results in developmental abnormalities. [101] Caspase-dependent apoptosis is activated by 
two major signaling pathways, intrinsic and extrinsic pathways. (Figure 1.6) [102] Intrinsic 
signals such as DNA damage, hypoxia, ER stress and metabolic stress stimulate the activation 
of BCL-2 homology 3 (BH3)-only proteins, which up-regulate pro-apoptotic molecules including 
bax, bak, bcl2 binding component 3 (bbc3; puma), noxa and sequester anti-apoptotic 
molecules such as bcl2 and bcl2-xl. The activation of Bax and bak induces the mitochondrial 
outer membrane permeabilization, which causes the release of second mitochondria-derived 
activator of caspases (SMAC) and cytochrome c. The association of cytochrome c and 
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apoptotic protease activating factor 1 (APAF1) then activates caspase 9. Subsequently, 
caspase-9 activates the effector caspase-3 and -7 to execute apoptosis. [103-105] The 
extrinsic signaling pathways initiate apoptosis via transmembrane receptor-mediated 
interactions. The most characterized ligands and the death receptors are FasL/FasR and TNF-
α/TNFR1. FasL/FasR recruits Fas-associated protein with a death domain (FADD). TNF-
α/TNFR1 recruits TNF receptor 1-associated death domain protein (TRADD) with FADD and 
RIP. [97, 106, 107] Furthermore, FADD associates with procaspase 8, which can be further 
activated by death-inducing signaling complex (DISC). [108] Caspase 8 then activates 
caspase 3 to initiate apoptosis. Caspase 8 can also cleave BH3-interacting domain death 
agonist (BID). The truncated Bid translocates to the mitochondria and then promotes the 
release of cytochrome c; furthermore, triggering apoptosis. [97, 102, 109] 
 
1.11 Techniques of establishing loss-of-function model in zebrafish 
Creating loss-of-function model is essential in studying gene function. Several gene silencing 
and editing strategies are available for achieving this purpose in zebrafish. 
 
1.11.1 Morpholinos 
Antisense morpholinos (MOs) are the most commonly used gene knockdown tool in zebrafish. 
MO oligonucleotides are altered DNA analogs that possess methylenemorpholine rings linked 
through non-ionic phosphorodiamidate groups.  The sequence of MO is usually around 25 
base pair long and binds to the targeted nucleotide sequences by Watson-Crick base-pairing. 
MO interferes with proper protein synthesis either by blocking the splicing process of pre-
mRNA or the translation. [57, 110] MO blocks pre-mRNA splicing by inhibiting the binding of 
splicing-directing small nuclear ribonucleoproteins (snRNP) complexes to the intron borders of 
the pre-mRNA, or by preventing the forming of the splice lariat structures. [111] The modified 
pre-mRNA splicing results in the synthesis of complete or partial intron inclusions or exon 
exclusions of mRNA. As for translation blocking morpholinos, it targets to the start codon or 
the 5'-untranslated region (UTR) of the mRNA and prevent the translation machinery from 
binding. [57, 110] 
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1.11.2 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
Genome editing technologies have been widely used for generating zebrafish mutants to study 
the function of genes. In addition to zinc finger nucleases (ZFNs) and transcription-activator-
like effector nucleases (TALENs), Clustered Regularly Interspaced Short Palindromic Repeats 
(CRISPR) has become the most popular genome editing tool in recent years due to its flexibility 
and simplicity of the experimental setup. [112] CRISPR was originally discovered in bacteria 
where it functions as a type II adaptive immune defense system against foreign DNA elements 
such as phage infection. Re-infection creates the complementary mature CRISPR RNA 
(crRNA) and recruits CRISPR-associated nuclease (Cas) to form a double-strand cut at the 
targeted DNA sequence. [113, 114] The typical CRISPR/Cas9 technology requires a short 
guide RNA (sgRNA) and a Cas9. The sgRNA is designed to contain a 20-nucleotide sequence 
for targeting the genome of interest and a scaffold sequence for Cas9 binding. The targeting 
site in the genome of interest has to be at the upstream of a protospacer adjacent motif (PAM) 
sequence. When sgRNA and Cas9 targets to the PAM sequence, it activates the HNH and 
RuvC domains of Cas9 and creates the double-strand cleavage in the targeting sequence. 
Subsequently, the double strand break is repaired by either non-homologous end joining 
(NHEJ) or the homology-directed repair (HDR) pathway. [113, 115, 116] Using CRISPR/Cas9 
system, NHEJ is the dominant repair pathway, an error-prone repair system which creates 
random insertions or deletions (Indels) of the sequence. Depending on the number of bases, 
indels generate premature stop codons or affect protein functions. [117-119]  
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2. AIM  
ADPGK converts glucose to glucose-6-phosphate in the ER and it has been described so far 
that PMA stimulates ADPGK induction in T cells. The activation of ADPGK accompanies the 
alteration of ROS signaling and glucose metabolism in T cells. However, the function of adpgk 
is poorly understood. 
Due to the strong expression of adpgk in high proliferative cells, we aimed to characterize its 
role in embryonic development using the zebrafish model. Overall, we hypothesized in this 
study that adpgk mediates glucose metabolism and regulates the developmental signaling 
pathways by controlling the posttranslational protein glycosylation modification during 
embryonic development in zebrafish.  
For the purpose of investigation, we focused on the following perspectives in this study 
1. Establishment of loss-of-function adpgk zebrafish model using CRISPR and morpholino 
including genotyping and phenotyping 
2. RT-qPCR screening of the signal transduction pathways; including the developmental, 
oxidative and cell death signaling pathways. 
3. Targeted metabolomics study including the LC-MS/MS method establishment for 
measuring the glucose intermediates and the quantification of the glucose intermediates, 
energy metabolites and the amino acids. 
4. Glycomics study of the differential n-glycan patterning in adpgk knockout zebrafish 
embryos. 
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3. MATERIALS  
3.1 Sequences of morpholinos and primers  
3.1.1 Morpholinos 
Name Sequence 
adpgk MO1 GTGTTCTCCAAGTTGCTCACCCCAC 
adpgk MO2 CAGCACAGCCTTCCTCCACATGA 
adpgk CO  GTATTATCCAAATTGCTAACCCAAC 
p53 MO GCGCCATTGCTTTGCAAGAATTG 
 
3.1.2  Genotyping  
Name Sequence 
MO1 #1 FW CTCCACATACACACACTCTCTGC 
RE CGTGCGATCCTCTGGAAAAC 
MO1 #2 FW GTGTCTGTCAGGTCCTCTGTGTG 
 RE TTGCAGTGGGGTGAGCAACTT 
 
3.1.3  CRISPR  
Name Sequence 
sgRNA #1 FW ACAAGCGGTGTTGGCGCTGGGGAT 
RE AAACATCCCCAGCGCCAACACCGC 
sgRNA #2 FW CACCCCGCCCACCCACACTGGAGG 
RE AAACCCTCCAGTGTGGGTGGGCGG 
 
3.1.4 Primer list_ adpgk mRNA for rescue  
Name Sequence 
zebrafish adpgk 
rescue 
FW GAGAGGGATCCCTCAACTTCTCCACATACA 
RE GAAGAGAATTCGGATGTTTCTTTTTATTTGAGTGA 
human  
adpgk rescue 
FW GAGAGATCGATGTAGCGCTTGTGTCG 
RE GAAGAGAATTCCCTGAAATGTAAATTGTTTTTAATATAT
TTAAGAG 
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3.1.5 Primer list_ In situ hybridization probe 
Name  Sequence 
adpgk  FW CGCTGGGGATGGGTTATCTC 
 RE CCACAGCCTCTTTGAGTCGT 
chordin FW CGCAAAGACACACACACT 
 RE TCTGAAGGGTTGCGTCTGAT 
dlx3 FW GTGTTACAGGCATCGTCCCA 
 RE CTGTGCTCTAGCGGAACCTC 
hgg1 FW AAGAGACCGCCTCTATGTTCG 
 RE TGACTGCTCAGAATCCAGCC 
ntl FW AGACGAATGTTTCCCGTGCT 
 RE GAACCAGCCACCGAGTTGT 
runx1 FW TGGGACGCCAAATACGAACC 
 RE TGCTCATACGACCAGGATGG 
wnt11 FW CGTGGTGTATCTTGACCGTTG 
 RE CCTGTCTGCCAACAGCATTG 
 
3.1.6 Primer list_qPCR 
Name  Sequence 
adpgk  FW CGCTGGGGATGGGTTATCTC 
 RE GTAGCACCTCGTGGTCTCTG 
adpgk  FW TCA GAT AAG GAG GTT TTC CAG AGG AT 
 RE CGT TTC CGC CCA CAT AAA GC 
axin2 FW CAATGGACGAAAGGAAAGATCC 
 RE AGAAGTACGTGACTACCGTC 
badb FW CAGCTCCTCCTGCTTTGTGG 
 RE CTTTTTACTCTCTTCATCTGCCCT 
bbc3 FW ACATCCCCTCACATGATGCC  
 RE TCTGTTCCTGAATTGTCCCTGAG  
bcl2 FW GGAAAATGGAGGTTGGGATGC 
 RE AAACGGGTGGAACACAGAGT  
bcl2l FW GCAGATTGTGTTATGGGTATGAGC 
 RE TGTTGCTCGTTCTCCGATGT  
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ca9 FW TCAAGGAATCTAGTGCTCATCCA 
 RE TGTGCTGTCGATACGTGTAA 
cdkn1a FW GCAGAAGCTCAAAACATATTGTCAC  
 RE CGATGCGTCCTCCAGATCG  
ef1a FW ACCGGCCATCTGATCTACAA 
 RE CAATGGTGATACCACGCTCA 
gadd45aa FW GTCCCTCAATGTGGACCCTG  
 RE GTTGATGTCGTTCTCGCAGC 
gli1 FW CAGACGTCCTCTCGCCTTAC 
 RE AGTAGCGCTGTCCTTGCATT 
hk1  FW GGTGAATTGGACGAAGGGCTTTAA 
 RE CCTCTTGATCCCCTCTCTCAGAAG 
hk4 FW TGAACGACACAGTAGCCACC  
 RE GCCTGTACCTACTATCATGCCG  
mycb FW CAGCGAATCCGATGACGAAGA 
 RE TCTCTTTTCCACCGTGACCA  
nqo1 FW AGAATCCCGAGCACTTTGTGT  
 RE CTTCTGCGATCAAGCTGAAAGAT  
ptch1 FW GCCGCATCCCAGGCCAACAT 
 RE CGTCTCGCGAAGCCCGTTGA 
rab1ab FW GATTGACCGCTACGCCAGT  
 RE CAAATTCCTTTGCCGTTGTGTA  
rb1 FW GCCCCTAAACCCCTGAAGAG 
 RE CTCGCCACTGGATTTGCTTC  
shha FW GGGAGCGGACAGGCTCAT 
 RE GCCAGTGGTTCATTACAGAGATGG 
slc2a1a FW TAAACCGCTTTGGCAGGAGG 
 RE AGACCCACAATGAACCGTCC 
stat1a FW TAGAAAGCCACGACTGGGAC  
 RE CTCCATCACGAAGCGACTGT  
txnrd1 FW GTGGCTTTCTGGCTGGTTTG  
 RE AGCTGCTCGATCTTAGTGGG  
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3.2 Antibodies 
Name Company 
anti-ADPGK  Sigma-Aldrich, St. Louis, U.S.A. 
anti-Calreticulin  Abcam, Cambridge, UK 
Anti-Digoxigenin-AP, Fab fragments Roche, Basel, Switzerland 
anti-GFAT1 Santa Cruz Biotechnology, Dallas, U.S.A. 
anti-Rac1/2/3  
Cell signaling Technology, Danvers, 
U.S.A. 
anti-β-actin  Santa Cruz Biotechnology, Dallas, U.S.A. 
Chicken Anti-Mouse IgG H&L (HRP) Abcam, Cambridge, UK 
Chicken Anti-Rabbit IgG H&L (HRP) Abcam, Cambridge, UK 
ConA Vector Laboratories, Burlingham, USA. 
SNA Vector Laboratories, Burlingham, USA. 
Streptavidin-HRP anti-biotin IgG  Vector Laboratories, Burlingham, USA. 
WGA Vector Laboratories, Burlingham, USA. 
 
3.3 Chemicals 
Name Company 
2-mercaptoethanol Merck, Darmstadt, Germany 
2-propanol Carl Roth, Karlsruhe, Germany 
6-aminocaproic acid Sigma-Aldrich, St. Louis, U.S.A. 
Acetic acid Carl Roth, Karlsruhe, Germany 
Acetone Sigma-Aldrich, St. Louis, U.S.A. 
Agarose Carl Roth, Karlsruhe, Germany 
Amino persulfate (APS) Sigma-Aldrich, St. Louis, U.S.A. 
Ammonium bicarbonate Sigma-Aldrich, St. Louis, U.S.A. 
Ampicilin PanReac AppliChem, Darmstadt, Germany 
Bacteriological agar Sigma-Aldrich, St. Louis, U.S.A. 
Bovine serum albumin (BSA) Santa Cruz Biotechnology, Dallas, U.S.A. 
Bromophenoblue Merck, Darmstadt, Germany 
C3-lactate Sigma-Aldrich, St. Louis, U.S.A. 
Calcium chloride (CaCl) Sigma-Aldrich, St. Louis, U.S.A. 
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Citric acid monohydrate Carl Roth, Karlsruhe, Germany 
Diethyl pyrocarbonate (DEPC) Sigma-Aldrich, St. Louis, U.S.A. 
Dipotassium phosphate (K2HPO4) Sigma-Aldrich, St. Louis, U.S.A. 
Dithiothreitol (DTT) Merck, Darmstadt, Germany 
Ethanol Carl Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid disodium salt 
dihydrate (EDTA) 
Carl Roth, Karlsruhe, Germany 
 
Formaldehyde Sigma-Aldrich, St. Louis, U.S.A. 
Formamide Sigma-Aldrich, St. Louis, U.S.A. 
Fructose-1,6-bisphosphate (FBP) Sigma-Aldrich, St. Louis, U.S.A. 
Glucose-6-phosphate (G6P) Sigma-Aldrich, St. Louis, U.S.A. 
Glyceraldehyde-3-phosphate (GAP) Sigma-Aldrich, St. Louis, U.S.A. 
Glycerol Sigma-Aldrich, St. Louis, U.S.A. 
Glycine Sigma-Aldrich, St. Louis, U.S.A. 
Perchloric acid (HClO4) Sigma-Aldrich, St. Louis, U.S.A. 
Hydrogen chloride Sigma-Aldrich, St. Louis, U.S.A. 
Iodoacetamide (IAA) Sigma-Aldrich, St. Louis, U.S.A. 
Lithium chloride (LiCl) Applichem, Darmstadt , Germany 
Magnesium chloride 6-hydrate (MgCl) 
PanReac AppliChem, Gatersleben, 
Germany 
Methanol Carl Roth, Karlsruhe, Germany 
Milk powder Carl Roth, Karlsruhe, Germany 
Monopotassium phosphate (KH2PO4) Sigma-Aldrich, St. Louis, U.S.A. 
N,N,N′,N′-Tetramethylethylenediamine (TEMED) 
Sigma-Aldrich, St. Louis, U.S.A. 
 
Nicotinamide adenine dinucleotide (NADH) Sigma-Aldrich, St. Louis, U.S.A. 
Paraformaldehyde (PFA) Merck, Darmstadt, Germany 
Phosphoenolpyruvate (PEP) Sigma-Aldrich, St. Louis, U.S.A. 
Potassium bicarbonate (KHCO3) Sigma-Aldrich, St. Louis, U.S.A. 
Potassium chloride (KCl) Carl Roth, Karlsruhe, Germany 
Potassium hydroxide (KOH) Sigma-Aldrich, St. Louis, U.S.A. 
Potassium phosphate (K3PO4) Sigma-Aldrich, St. Louis, U.S.A. 
Proteinase inhibitor Roche, Basel, Switzerland 
Proteinase K Carl Roth, Karlsruhe, Germany 
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Pyruvate (PYR) Sigma-Aldrich, St. Louis, U.S.A. 
Ribonucleic acid from torula yeast, type IV RNA Sigma-Aldrich, St. Louis, U.S.A. 
Ribulose-5-phosphate (Ru5P) Sigma-Aldrich, St. Louis, U.S.A. 
Sodium bicarbonate (NaHCO3) 
PanReac AppliChem, Gatersleben, 
Germany 
Sodium carbonate anhydrous (Na2CO3) Carl Roth, Karlsruhe, Germany 
Sodium chloride (NaCl) Carl Roth, Karlsruhe, Germany 
Sodium deoxycholate Sigma-Aldrich, St. Louis, U.S.A. 
Sodium dodecyl sulfate (SDS) pellet SERVA, Heidelberg, Germany 
Sodium hydroxide Carl Roth, Karlsruhe, Germany 
Sulfosalicylic acid Sigma-Aldrich, St. Louis, U.S.A. 
Tributylamine Sigma-Aldrich, St. Louis, U.S.A. 
Tris base Carl Roth, Karlsruhe, Germany 
Triton X-100 Carl Roth, Karlsruhe, Germany 
Trypton Carl Roth, Karlsruhe, Germany 
Tween 20 Carl Roth, Karlsruhe, Germany 
Urea Sigma-Aldrich, St. Louis, U.S.A. 
Yeast extract Sigma-Aldrich, St. Louis, U.S.A. 
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3.4 Reagents 
Name Company 
40% acrylamide and bis-acrylamide solution Bio-Rad, Hercules, U.S.A. 
Acridine orange Sigma-Aldrich, St. Louis, U.S.A. 
BamHI restriction enzyme Thermo Fisher Scientific, Waltham, U.S.A. 
Bbsl restriction enzyme Thermo Fisher Scientific, Waltham, U.S.A. 
Bsu15I restriction enzyme Thermo Fisher Scientific, Waltham, U.S.A. 
Digoxigenin-RNA labeling mix  Roche, Basel, Switzerland 
DNase I, RNase free  Thermo Fisher Scientific, Waltham, U.S.A. 
EcoRI restriction enzyme Thermo Fisher Scientific, Waltham, U.S.A. 
GeneRuler 1 kb DNA Ladder Thermo Fisher Scientific, Waltham, U.S.A 
GeneRuler 100 bp DNA Ladder Thermo Fisher Scientific, Waltham, U.S.A 
Latate dehydrogenase (LDH) Sigma-Aldrich, St. Louis, U.S.A. 
Lowry assay  Bio-Rad, Hercules, U.S.A. 
MyTaq HS red mix  Bioline, London, UK 
NBT/BCIP Stock Solution Roche, Basel, Switzerland 
Not I restriction enzyme Thermo Fisher Scientific, Waltham, U.S.A. 
PageRuler prestained protein ladder New England BioLabs, Ipswich, U.S.A. 
Phusion PCR  New England BioLabs, Ipswich, U.S.A. 
PNGaseF New England BioLabs, Ipswich, U.S.A. 
Q5® High-Fidelity DNA polymerase  New England BioLabs, Ipswich, U.S.A. 
RNase inhibitor  Roche, Basel, Switzerland 
S.O.C. medium  New England BioLabs, Ipswich, U.S.A. 
SensiFAST™ SYBR®  Bioline, London, UK 
SP6 or T7 polymerase  Roche, Basel, Switzerland 
SSC buffer 20x concentrate Sigma-Aldrich, St. Louis, U.S.A. 
SuperSignal™ West Pico chemiluminescent 
Substrate 
Thermo Fisher Scientific, Waltham, U.S.A. 
 
T4 ligase  New England BioLabs, Ipswich, U.S.A. 
T4 polynucleotide kinase New England BioLabs, Ipswich, U.S.A 
Trizol reagent Thermo Fisher Scientific, Waltham, U.S.A. 
XbaI restriction enzyme Thermo Fisher Scientific, Waltham, U.S.A. 
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3.5 Kits  
Name Company 
GeneJET plasmid miniprep kit Thermo Fisher Scientific, Waltham, U.S.A. 
GenElute(TM) gel extraction kit Sigma-Aldrich, St. Louis, U.S.A. 
Glucose colorimetric kit Cayman, Ellsworth, U.S.A. 
HiSpeed plasmid midi kit  Qiagen, Hilden, Germany 
Maxima first strand cDNA synthesis kit for  
RT-qPCR  Thermo Fisher Scientific, Waltham, U.S.A. 
MEGAscript ® T7 in vitro transcription kit Thermo Fisher Scientific, Waltham, U.S.A. 
mMESSAGE mMACHINE® T3 in vitro 
transcription kit  Thermo Fisher Scientific, Waltham, U.S.A. 
NEB 5-α competent E.coli New England BioLabs, Ipswich, U.S.A. 
Signal transduction PathwayFinder PCR array Qiagen, Hilden, Germany 
Topo TA cloning kit dual promotor  
Invitrogen/Thermo Fisher Scientific, 
Waltham, U.S.A. 
TUNEL assay Roche, Basel, Switzerland 
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3.6 Machines and Devices 
Name Sequence 
Acquity BEH C18 column 150 mm × 2.1 mm, 
1.7 µm 
Waters, Milford, Massachusetts, U.S.A 
 
Autoclave Systec, Linden, Germany 
Biochrom 30+ cation exchange 
chromatography  
Biochrom, Cambridge, UK 
 
Blotting semidry system PeqLab, Erlangen, Germany 
C1000 Touch Thermo Cycler Bio-Rad,Hercules, U.S.A. 
Centrifuge Heraeus instrument  Heraeus, Hanau, Germany 
CFX Connect Real Time System Bio-Rad, Hercules, U.S.A. 
Electrophoresis chamber Bio-Rad, Hercules, U.S.A. 
FemtoJet micro-injector  Eppendorf, Hamburg, Germany 
Fluoresence microscope Olympus U-RFL-T, Tokyo, Japan 
Fusion-SL Advance 4.2 MP  Peqlab, Erlangen, Germany 
Herathermo incubator Thermo Fisher Scientific, Waltham, U.S.A. 
LC-FLR-QTOF-MS Waters, Milford, Massachusetts, U.S.A. 
Microloader 20 μL Eppendorf, Hamburg, Germany 
Micromass Quattro Ultima LC-MS/MS Waters, Milford, Massachusetts, U.S.A 
Microscope Olympus SZX16, Tokyo, Japan 
Microwave Sharp, Osaka, Japan 
NanoDrop LiTe spectrophotometer Thermo Fisher Scientific, Waltham, U.S.A. 
Olympus AU400  Beckman Coulter, Brea, U.S.A. 
Phenomenex Synergi™ 4 µm Hydro-RP 80 
Å, 150 × 2 mm  Phenomenex, Torrance, U.S.A. 
pH-Meter  WTW, Weilheim , Germany 
SDS PAGE electrophoresis system Bio-Rad, Hercules, U.S.A. 
Sonicator Branson, Dietzenbach, Germany  
Spectamax Plus 384 Molecular Devices, Sunnyvale, U.S.A. 
Ultracentrifuge Typ Optima TLX Beckman Coulter, Brea, U.S.A. 
UV-Handlampe VL-4.LC  Vilber, Eberhardzell, Germany 
UV-Transilluminator CN-TFX  Vilber, Eberhardzell, Germany 
Waters BEH Glycan amide column 150 ×1.0 
mm ID, 1.7 µm Waters, Milford, Massachusetts, U.S.A 
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Weighing machine PH204L  Mettler Toledo, Greifensee, Switzerland  
Weighing machine XP56  Mettler Toledo, Greifensee, Switzerland  
 
3.7 Disposables 
Name Company 
0.45 µm nitrocellulose membrane Neolab, Heidelberg, Germany 
10cm dish Sarstedt, Nümbrecht,Germany 
Amicon Ultra-0.5 mL centrifugal 10 kDa 
filter 
Merck, Darmstadt, Germany 
Hard-Shell® 96-well PCR Plates, thin wall Bio-Rad, Hercules, U.S.A 
Microseal® 'B' PCR plate sealing film  Bio-Rad, Hercules, U.S.A 
PCR tube (0.2 ml) Sarstedt, Nümbrecht,Germany 
Thin wall capillary, 1.0 mm World Precision Instruments, Berlin, 
Germany 
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4. METHODS 
4.1 Zebrafish husbandry 
Wild-type AB (Danio rerio), and transgenic zebrafish Tg (myl7:GFP) and Tg (kdrl:GFP, 
gata1:dsRed) were maintained at 28.5°C on a 14-hour light/10-hour dark cycle. Embryos 
collected from natural mating were cultured in embryo E3 medium (150 mM NaCl, 0.5 mM KCl, 
1.0 mM CaCl2, 0.37 mM, KH2PO4, 0.05 mM Na2HPO4, 2.0 mM MgSO4, 0.71 mM NaHCO3 in 
deionized water, pH 7.4) and staged according to Kimmel et al. (Kimmel et al., 1995). The 
animals were held in accordance with the regulations of the University Heidelberg and the 
Regierungspräsidium Karlsruhe. 
 
4.2 Generation of the CRISPR-based adpgk mutants 
4.2.1 Cloning of the guide RNAs  
Two guide RNAs targeting different regions of adpgk were designed from DKFZ E-CRISPR 
(www.e-crisp.org). The targeting sequences were GCGGTGTTGGCGCTGGGGAT and 
CCGCCCACCCACACTGGAGG. Firstly, the oligos (sgRNA sequences) were annealed and 
phosphorylated using T4 Polynucleotide Kinase. The annealing was carried out at the 
thermocycler with 37 oC for 30 minutes and 95 oC for 5 minutes with the ramp of 5 oC/minutes 
down to 25 oC. The annealed oligos were then ligated with the Bbsl digested and purified px330 
plasmid with the concentration ratio of 1:3 using T4 DNA Ligase (New England BioLabs, 
Ipswich, U.S.A.) for overnight incubation. The ligate was cloned and transformed into NEB 5-
α competent E.coli. Briefly, the ligated oligo-px330 plasmid was added to the NEB 5-α 
competent E.coli cells and mixed by gently flicking. After 30 minutes of incubation on ice, the 
heat shock reaction was carried out at 42 oC for exactly 30 seconds. Subsequently, the 
competent E.coli were incubated on ice for 5 minutes, diluted by S.O.C. medium and incubated 
at 37oC for 1 hour shaking at 300 rpm. One hundred microliter of the diluted cells were spread 
on a LB agar plate (1.5 % bacterial agar, 1 % tryptone, 0.5 % yeast extract, and 1 % NaCl in 
sterilized water) with 100 μg/ml ampicillin. After the overnight incubation at 37oC, colonies were 
picked and cultured in the LB broth (1 % tryptone, 0.5 % yeast extract, and 1 % NaCl in 
sterilized water) for mini plasmid (GeneJET Plasmid Miniprep Kit) preparation. The extracted 
DNA plasmid was then sent out for sequencing (Seqlab, Göttingen, Germany). The plasmid 
with the correct oligo sequence was amplified by midi plasmid culture and further purified. 
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4.2.2 Guide RNAs and Cas9 mRNA synthesis 
The oligo-px330 plasmid was fused with T7 promoter using Phusion PCR. The T7-oligo-px330 
plasmid was used as the template for guide RNAs synthesis using MEGAscript ® T7 in vitro 
Transcription Kit. The plasmid of zebrafish Cas9, pT3TS-nCas9n, was linearized by Xbal 
restriction enzyme and transcribed to Cas9 RNA using mMESSAGE mMACHINE® T3 in vitro 
Transcription Kit following the manufacture’s instruction. Briefly, the plasmid template was 
mixed with reaction buffer, enzyme mix and NTP mix and incubated at 37oC overnight.  
The synthetic sgRNAs and Cas 9 RNA were purified using lithium chloride precipitation. To be 
short, the RNA probe was mixed with DEPC-water and 7.5 M lithium chloride followed by 
incubating at -20 oC for at least 30 minutes. After centrifuging at 13000 rpm for 15 minutes and 
washing with 70 % methanol, the RNA pellet was dissolved in DEPC-water.  
4.2.3 Microinjection of the guide RNA and Cas9 
The concentration was determined by NanoDrop LiTe Spectrophotometer. Two guide RNAs 
and Cas9 were then mixed at the final concentration of 200 ng/dL and 300 ng/dL, respectively. 
Two nl of the mixture of guide RNAs and Cas9 was injected into the embryos at one cell stage 
using FemtoJet micro-injector. 
4.2.4 Genotyping of the CRISPR mutants 
The genotyping was performed in 24 hour post fertilization (hpf) embryos or adult zebrafish. 
The genomic DNA was extracted from the embryos or clipped fin. Briefly, the embryos or fin 
were dissolved in 75 μl Buffer A (25 mM NaOH, 0.2 mM Na2EDTA) at 95 oC for 15 minutes 
and mixed with 75 μl Buffer B (40 mM HCl). The genomic DNA was amplified with adpgk 
primers by PCR. The PCR product was then purified and cloned into the Topoisomerase I-
activated pCR™II-TOPO® vector following by transformation into NEB 5-α competent E.coli. 
The plasmids were further amplified by mini culture. The purified plasmid was sent out for 
sequencing. 
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4.3 Establishment of the Morpholino-based knockdown model  
4.3.1 Morpholinos 
In the morphlino based adpgk knockdown (KD) model, we used three morpholinos: two 
morpholinos (MO) targeting adpgk and one control morpholino, which were custom-
synthesized by Gene Tools (Philomath, U.S.A.). The splice blocking morpholino targeting the 
junction of exon 2 and intron 2 (MO1 for KD1): GTGTTCTCCAAGTTGCTCACCCCAC. The 
translation blocking morpholino targeting at the start codon (MO2 for KD2): 
CAGCACAGCCTTCCTCCACATGA. The control morpholino (CO) was the mismatch of splice 
blocking morpholino: GTATTATCCAAATTGCTAACCCAAC. The morpholinos were first 
reconstituted in sterilized water to make the stock solution of 300 mM. Besides the study of 
concentration dependency, the injection concentration was 300 μM for MO1, 250 μM for MO2 
and 300 μM for CO.  
In addition, we also used p53 MO in our apoptosis study. p53 MO 
(GCGCCATTGCTTTGCAAGAATTG) was also synthesized by Gene Tools (Philomath, 
U.S.A.). We injected 300 μM of p53 MO in together with 300 μM of MO1 into the embryos.  
4.3.2 Adpgk rescue mRNA generation 
The zebrafish or human cDNA was synthesized (the detailed procedures were indicated as 
below) and used as template for zebrafish or human adpgk amplification by PCR. The PCR 
was performed using Q5® High-Fidelity DNA Polymerase with an annealing temperature at 60 
oC. Briefly, the primers were designed with the overhang sequence containing BamHI and 
EcoRI restriction sites in zebrafish adpgk primers, and Bsu15I and EcoR1 in human adpgk 
primers. After amplification, the PCR products were loaded on a 1 % agarose gel for 
electrophoresis. Subsequently, we cut out the bands of adpgk and performed gel elutions using 
GenElute(TM) Gel Extraction Kit. The purified zebrafish and human adpgk was digested with 
BamHI and EcoRI, and with Bsu15I and EcoRI, respectively. Accordingly, the PCS2+ vector 
plasmids were also digested with the same restriction enzymes as for zebrafish and human 
adpgk cloning. The linearized zebrafish and human adpgk were ligated separately with the 
linearized PCS+ vector with the concentration ratio of 1:3 using T4 DNA Ligase and incubated 
on ice overnight. The ligate was transformed into NEB 5-α competent E.coli. The plasmid was 
purified from mini bacterial culture, sequenced and after further inoculation for midi culture 
again purified. Afterwards, the plasmid was digested with NotI restriction enzyme and used as 
the template for mRNA synthesis using MEGAscript ® T7 in vitro Transcription Kit. In short, 
the plasmid template was mixed with reaction buffer, enzyme mix and NTP mix and incubated 
at 37oC overnight. Subsequently, the synthetic RNA was purified by lithium chloride solution 
and dissolved in DEPC-water.  
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4.3.3 Dishevelled rescue mRNA generation 
Plasmids containing Dishevelled, Dishevelled_ΔC and Dishevelled_ΔN came from Dr. 
Matthias Carl. The plasmids were transformed into NEB 5-α competent E.coli. After mini 
plasmid purification, sequencing and midi purification, the plasmids were digested with NotI 
restriction enzyme and used as template for in vitro transcription. The template was mixed with 
Sp6 polymerase, reaction buffer, and NTP mix and incubated at 37 oC overnight. Subsequently, 
the synthetic RNA was purified by lithium chloride solution and dissolved in DEPC-water.  
4.3.4 Microinjection of the rescue experiment 
The concentration of the mRNAs was determined by NanoDrop LiTe Spectrophotometer. The 
rescue mRNA was diluted with sterilized water and mixed with the morpholinos. The injection 
concentration used is mentioned in the results. Two nanoliter of the mixture was injected into 
embryos at one cell stage. 
 
4.4 RNA extraction and cDNA synthesis  
The embryos were collected and homogenized by mixing them with 1 ml Trizol followed by an 
incubation for 5 minutes at room temperature. The homogenate was subsequently mixed with 
200 μl chloroform and incubated for 2 minutes. After centrifuging at 7500 ×g for 15 minutes at 
4 oC, the upper aqueous phase was taken and gently mixed with 500 μl isopropanol. The 
mixture was incubated at -80 oC for 30 minutes and subsequently centrifuged at 7500 ×g for 
10 minutes at 4 oC to pellet the RNA. The supernatant was discarded and the RNA pellet was 
washed twice with 500 μl ice-cold ethanol. After centrifugation at 7500 ×g for 10 minutes at 4 
oC, the RNA pellet was dried at room temperature and dissolved with DEPC-H2O. The RNA 
was stored at -80 oC. 
Prior to cDNA synthesis, RNA was treated with DNase I, RNase free, to remove the residual 
DNA. The cDNA synthesis was carried out using Maxima First Strand cDNA Synthesis Kit for 
RT-qPCR. Briefly, 1000 ng of RNA template were mixed with the reaction buffer and enzyme 
mix. The mixture was incubated for 10 minutes at 25 oC followed by 15 minutes at 65 oC. The 
reaction was terminated by heat inactivation at 85 oC for 5 minutes. The cDNA was stored at -
80 oC.  
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4.5 Real time-quantitive PCR (RT-qPCR) 
The gene expression was measured using RT-qPCR. The synthesized cDNA was used as 
template and mixed with the master mix containing SensiFAST™ SYBR®, H2O and primers of 
the targeted gene, in the 96-well. For the broad pathway screening, the signal transduction 
PathwayFinder PCR array (Qiagen, Hilden, Germany) was used. The plate was sealed with 
Microseal®membrane and centrifuged at 4000 ×g for 2 minutes at room temperature. RT-qPCR 
was carried out using CFX Connect Real Time System. Program used for targeted gene 
quantification was as followed. 
95 oC 0:25 
95 oC 0:03  
60oC 0:30 40 cycles 
95 oC 0:15 
Melt curve 65 oC to 95 oC, increment 0.5 oC 1:00 
60 oC 0:15 
Program used for signal transduction pathway array 
95 oC 10:00 
95 oC 0:15  
60oC 1:00 39 cycles, 1 oC ramp/sec 
95 oC 0:10 
Melt curve 65 oC to 95 oC, increment 0.5 oC 1:00 
 
4.6 In situ hybridization 
4.6.1 Cloning and generation of the in situ probe  
Adpgk, wnt11, runx1, hgg1, dlx3, ntl, chordin and sox17 were amplified by PCR. The reaction 
was carried out using zebrafish cDNA as template adding the specific primers and MyTaq HS 
Red Mix. The PCR products were loaded onto a 1 % agarose gel. After gel electrophoresis, 
we cut out the bands of the targeted genes and performed gel elutions using GenElute(TM) Gel 
Extraction Kit. The purified genes were cloned into a Topoisomerase I-activated pCR™II-
TOPO® vector using Topo TA Cloning Kit Dual Promotor following the manufacture’s 
instruction. In short, the PCR product of the gene of interest was mixed with salt solution and 
vector. After incubating at room temperature for 5 minutes and on ice for 30 minutes, the ligate 
was transformed into NEB 5-α competent E.coli. Subsequently, the transformed competent 
E.coli were cultured, amplified and purified. The extracted DNA plasmid was then sent out for 
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sequencing (Seqlab, Göttingen, Germany). The plasmid with the correct target gene sequence 
was then amplified by midi plasmid preparation. The purified plasmid was digested with BamHI 
or NotI. The linearized plasmid was mixed with the transcription buffer, digoxigenin-RNA 
labeling mix (UTP), RNase inhibitor and SP6 or T7 polymerase for the in vitro transcription at 
37 oC overnight. The synthetic RNA probe was purified using lithium chloride precipitation and 
dissolved in DEPC-water.  
4.6.2 In situ hybridization staining 
Zebrafish embryos were collected at the desired stages and fixed with 4 % cold 
paraformaldehyde (PFA) in PBS (0.8 % NaCl, 0.02 % KCl, 0.02 M PO4, pH 7.4) at 4 oC 
overnight. After dechorionating, the embryos were hydrated by a serial incubation of 25 %, 50 
% and 75 % methanol in PBST (PBS and 0.1 % Tween) and 100 % methanol for 5 minutes 
each, and subsequently stored at -20 o.C at least overnight before use. The embryos were 
rehydrated in a serial incubation of 75 %, 50 % and 25 % methanol/PBST, and 100 % PBST 
for 5 minutes each, and digested with 10 ug/ml of Proteinase K in PBST. Following by washing 
three times with PBST, the embryos were re-fixed with 4% PFA for 20 minutes. The embryos 
were pre-hybridized in the hybridization buffer (50% formamide, 5× SSC, 50 μg/ml heparin, 
500 μg/ml tRNA, 9 mM citric acid, 0.1 % Tween 20 in DEPC-H2O) at 70 oC for 3 hours and 
subsequently hybridized with the in situ probe at 70 oC overnight.   
The hybridized embryos were washed with 25 %, 50 %, 75 % 2× SSC in hybridization buffer 
and 100 % 2× SSC each for 10 minutes and following by 2 times 30 minutes wash with 0.2× 
SSC at 70 oC. The embryos were incubated with 25 %, 50 % and 75 % PBST in 0.2× SSC and 
100 % PBST each for 5 minutes. After 4 hours of blocking (BSA 2 mg/ml and 2 % sheep serum 
in PBST), the embryos were incubated with anti-digoxigenin-AP, Fab fragments in blocking 
solution overnight at 4oC. 
The embryos were washed with PBST 4 times for 25 minutes and with alkaline phosphatase 
(AP) buffer (100 mM Tris HCl, 50 mM MgCl2, 100 mM NaCl and 0.1 % Tween in DEPC-H2O, 
pH 9.5) 3 times for 5 minutes; and subsequently stained with NBT/BCIP in AP Buffer. After the 
staining, the embryos were washed with PBS and stored in 70 % glycerol at 4oC. 
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4.7 Deyolking 
For western blot analysis, the embryos were deyolked. The embryos were mixed with 1 ml 
deyolking buffer (55 mM NaCl, 1.8 mM KCl and 1.25 mM NaHCO3) by pipetting up and down 
several times until the yolk was dissolved. The embryos were centrifuged at 5000 rpm, 1 
minute at 4 oC, and the supernatant was discarded. The pellets were washed twice with 
washing buffer (110 mM NaCl, 3.5 mM KCl, 2.7 mM CaCl2, 10 mM Tris/HCl, pH 8.5) followed 
by centrifuging at 5000 ×g, 1 minute at 4 oC. The pellets were dissolved with RIPA buffer (5 
mM Tris, 7.4 mM EDTA, 0.5 % NP40, 6 mM sodium deoxycholate, 0.05 % SDS and proteinase 
inhibitor, pH 7.5) and homogenated by sonication. After centrifuging at 13000 rpm for 20 
minutes at 4 oC, the supernatant was collected for further measurements.  
 
4.8 Protein measurement 
The protein concentration of the zebrafish samples were determined by Lowry assay. Five 
microliter of sample and bovine serum albumin (BSA) standards (0.1, 0.2, 0.5, 0.8, 1, 1.6, 2 
mg/mL of BSA) were pipetted in duplicate into a 96 well plate. Twenty-five microliter of Reagent 
A and 200 μl of reagent B were subsequently added into the 96 wells. After 15 minutes of 
mixing at room temperature, the absorbance at 750 nm was measured by a Spectamax Plus 
384 spectrophotometer.  
 
4.9 Western blot/lectin blot 
Protein samples (20 μg) were mixed with 6× SDS loading dye (480 mM Tris/HCl, 12 % SDS, 
45 % glycerol, 12 % β-mercaptoethanol, 0.06 % bromophenoblue, pH 6.8) and denatured at 
95 °C for 5 minutes. The denatured samples were loaded into wells and separated by SDS gel 
electrophoresis (4 % stacking gel: 40 % acrylamide, 0.5 M Tris/HCl pH 6.8, 10 % SDS, 10 % 
APS, TEMED, H2O; 10 % separating gel: 40 % acrylamide, 1.5 M Tris/HCl pH 8.8, 10 % SDS, 
10 % APS, TEMED, H2O) with 80 voltages for 30 minutes and then 130 voltages for 1 hour. 
Subsequently, the proteins were transferred to the 0.45 µm nitrocellulose membrane. The 
blotting was done using a semidry system (Anode Buffer: 75 mM Tris/HCl, 20 % methanol; 
Cathode Buffer: 25 mM Tris/HCl pH 9.0, 40 mM aminocapronic acid, 20 % methanol) with the 
current of 1 mA/cm2 for 50 minutes. The western blot was blocked with 5 % non-fat milk in 0.1 
% TBST followed by incubation with the primary anti-ADPGK (1:250 dilution), Rac1/2/3 (1:1000 
dilution), GFAT1 (1:500) or β-actin (1:1000) antibody at 4 oC overnight. After washing with 0.1 
% TBST 3 times for 10 minutes, the blot was incubated with secondary anti-rabbit (1:10000) 
or anti-mouse IgG (1:10000) antibody conjugated with Horseradish Peroxidase (HRP) at room 
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temperature for 1 hour.  
The lectin blot was blocked with 0.5 % TBST followed by incubation with the biotinylated ConA, 
SNA, or WGA or lectins (1:1000) at 4 oC overnight. After washing with 0.1 % TBST 3 times for 
10 minutes, the blot was incubated with the streptavidin-HRP anti-biotin IgG antibody (1:10000) 
at room temperature for 1 hour.  
The signal was developed using SuperSignal West Pico Chemiluminesent Substrate and 
detected using Fusion-SL Advance 4.2 MP. If reprobing was needed, the blot was washed 
three times with 0.1 % TBST and incubated with 10 % acetic acid for 10 minutes. After 
completely removing the 10 % acetic acid by washing with 0.1% TBST, the blot was re-blocked 
with 5 % non-fat milk for 30 minutes and incubated with primary antibody at 4 °C overnight.  
 
4.10 Acridine orange staining 
The live imaging of Acridine orange staining was used to determine the dead cells. The 
embryos were stained with 5 μg/μl acridine orange in E3 medium for 30 minutes followed by 
three times washing with PBS. The staining was then observed under fluorescence 
microscope with excitation/emission at 502/525 nm for green and 460/650 nm for red 
fluorescence. 
 
4.11 TUNEL assay 
The apoptotic cells were detected by Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay. Firstly, the embryos were fixed with 4 % PFA in PBS overnight. After 
the fixation, they were washed with PBS twice for 5 minutes and then dechorinated. The 
dehydration of the embryos was performed by incubating them in 50 % methanol in PBST for 
5 minutes and 100 % methanol for 5 minutes. Subsequently, the embryos were stored at -20 
oC for 12 hours or until use. The embryos were washed with acetone for 20 minutes followed 
by rehydration in a serial incubation of 75 % methanol, 50 % methanol, 25 % methanol and 
100% PBST for 5 minutes. Next, they were permeabilized with proteinase K for 5 minutes and 
fixed with 4 % PFA for 20 minutes. The PBST wash, proteinase K permeabilization and fixation 
steps were repeated one more time. After washing out the 4 % PFA with PBST (PBS, 1 % 
Triton-X) 3 times for 20 minutes, the embryos were stained with the TUNEL assay reagent (1:9 
enzyme solution: labeled solution) for 1 hour at dark at 37 oC. The stained embryos were 
washed with PBS twice for 5 minutes and stored in PBS until observation. The TUNEL staining 
was observed under a fluorescence microscope with FITC excitation/emission at 502/525 nm. 
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4.12 Glucose measurement 
The whole mount zebrafish glucose content was measured by a glucose colorimetric assay kit. 
Fifteen microliter of standard (0, 2.5, 5, 7.5, 10, 15, 20, 25 mg/dl) or zebrafish homogenate 
samples were mixed with 85 μl of diluted assay buffer in the 96 well plates. The reaction was 
initiated by adding 100 μl enzyme mixture to each wells. After 10 minutes incubation at 37 oC, 
the absorbance at 500-520 nm was measured using spectrophotometer. 
 
4.13 Lactate and pyruvate measurement 
The level of lactate and pyruvate in zebrafish embryos was measured based on the enzymatic 
assay. Zebrafish embryos were collected and homogenated in water. Depends on the pH, 
lactate dehydrogenase (LDH) determines the reversible conversion between pyruvate and 
lactate. At pH 7 LDH catalyzes the conversion of pyruvate and NADH to lactate and NAD+. At 
pH 9 LDH catalyzes the conversion of lactate and NAD+ to pyruvate and NADH. For pyruvate 
measurement the zebrafish homogenate was mixed with reaction buffer 1 containing NADH, 
1.5M Tris Base and 0.2 % HClO4 and then with reaction buffer 2 containing LDH. For the lactate 
measurement zebrafish homogenate was mixed with NADH, glycine buffer and LDH. The 
reaction and measurements were performed on the Olympus AU400. 
 
4.14 Adenosine and GSH/GSSH measurements 
Thirty embryos were homogenated in water and snap-frozen in liquid N2. The embryo 
homogenates were stored at -80 oC until measurement. The measurement including ATP, ADP, 
AMP, NADH, NAD, NADPH, SAM, SAH, MTA as well as GSH and GSSG was done in 
cooperation with the Metabolomics Core Facility of Heidelberg University. The following 
information regarding the detailed procedure of the measurement was provided by Dr. Gernot 
Poschet. “Metabolites were extracted from 30 zebrafish embryos with 0.3 ml of 0.1 M HCl in 
an ultrasonic ice-bath for 10 min. The resulting homogenates were centrifuged twice for 10 min 
at 4 °C and 16400 ×g to remove cell debris. AMP, ADP and ATP were derivatized with 
chloroacetaldehyde as described in Bürstenbinder et al. [120] and separated by reversed 
phase chromatography on an Acquity BEH C18 150 mm × 2.1 mm, 1.7 µm column connected 
to an Acquity H-class UPLC system. Prior separation, the column was heated to 42°C and 
equilibrated with 5 column volumes of buffer A (5.7 mM TBAS, 30.5 mM KH2PO4 pH 5.8) at a 
flow rate of 0.45 ml min-1. Separation of adenosine derivates was achieved by increasing the 
concentration of buffer B (2/3 acetonitrile in 1/3 buffer A) in buffer A as follows: 1 min 1 % B, 
1.6 min 2 % B, 3 min 4.5 % B, 3.7 min 11 % B, 10min 50 % B, and return to 1 % B in 2 min. 
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The separated derivates were detected by fluorescence (Acquity FLR detector, Waters, 
excitation: 280 nm, emission: 410 nm, gain: 100) and quantified using ultrapure standards. 
Data acquisition and processing was performed with the Empower3 software suite.”  
 
4.15 Glucose intermediates_LC-MS/MS measurement 
Zebrafish glucose-6-phosphate (G6P), fructose-1,6-bisphosphate (FBP), glyceraldehyde-3-
phosphate (GAP), phosphoenolpyruvate (PEP), pyruvate (PYR), and ribulose-5-phosphate 
(Ru5P) were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS). 
Zebrafish embryos were homogenated in water and snap-frozen in liquid N2. One hundred 
microliter of G6P, FBP, GAP, PEP, PYR and Ru5P standard (0, 0.1, 0.25, 0.5, 1, 2, 5, 10 μM) 
and zebrafish homogenate were mixed with 400 μl methanol containing internal standard (C3-
lactate) for de-proteinization. After centrifuging at 13000 rpm for 5 minutes at 4 oC, the 
supernatant was dried under N2. The samples were re-dissolved in H2O and filtered through 
10 kDa filter (Amicon Ultra-0.5 mL Centrifugal Filters, Merck, Darmstadt, Germany). The 
filtrates were collected and then injected into a Micromass Quattro Ultima (LC-MS/MS). The 
liquid chromatography separation was carried out by a Phenomenex Synergi™ 4 µm Hydro-
RP 80 Å, 150 × 2 mm column with the mobile phase of 10 mM tributylamine (pH 4.95) and 
methanol.  
 
4.16 Amino acid measurement 
Thirty embryos were homogenated in water and snap-frozen in liquid N2. The samples were 
then deproteinized with 20 % sulfosalicylic acid. After centrifuging, the supernatant was 
collected and injected into a Biochrom 30+ cation exchange chromatography. 
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4.17 Glycan measurement 
Two hundred zebrafish embryos were homogenated in UA buffer (8 M urea in Tris-HCl, pH 
8.5) and sonicated for three cycles (15 seconds on, 15 seconds off) on ice. After centrifuging 
at 16000 ×g for 10 minutes at 4 oC, the supernatant was collected for protein measurement. 
The aliquots of 2 mg of protein were transferred onto a 10 kDa MWCO filter (Amicon Ultra-
0.5 mL Centrifugal Filters) followed by centrifuging at 14000 ×g for 20 minutes. The 
concentrated samples were mixed with Dithiothreitol (DTT) in UA buffer (final concentration of 
10 mM), vortexed and incubated at room temperature for 30 minutes. Afterwards, the samples 
were centrifuged and mixed with iodoacetamide in UA buffer at a final concentration of 50 mM. 
After vortexing and incubation at room temperature for 30 minutes in the dark, the samples 
were centrifuged at least three times to exchange the buffer to 50 mM ammonium bicarbonate 
(ABC buffer, pH ~7.8). Two microliter of PNGaseF was added per filter and incubated at 37 ˚C 
overnight. The samples were centrifuged at 4 ˚C for 10 minutes and the filtrates were collected 
and dried using lyophilisation. The samples were sent out to National Institute for 
Bioprocessing Research and Training (NIBRT) in Ireland for glycan measurement.  
The glycans were first separated based on the degree of sialylation by weak Anion Exchange 
analysis/separation. The liquid chromatography was carried out using BioSuiteDEAE Anion-
exchange column, 1000 Å 10 μm, 7.5 mm x 75 mm (Waters; Milford, Massachusetts, U.S.A.) 
with 20 % AcCN (mobile phase A) and 100 mM Ammonium Acetate, 20 % AcCN pH 7.0 (mobile 
phase B). The fractions were collected and digested at 37 oC overnight with panels of 
exoglycosidase using 50 mM ammounium acetate pH 5.5 for glycan structure study. The 
exoglycosidase included α(2-3,6,8,9)-Sialidase, α(1-3,4)-Fucosidase, α(1-2,3,4,6)-Fucosidase, 
α(1-3,4,6)-Galactosidase, β(1-4)-Galactosidase, β(1-3,4)-Galactosidase and β-N-
acetylhexosaminidase. The glycans were separated and detected by a Waters Acquity UPLC 
system equipped with an online fluorescence detector and Quadrupole Time-of-Flight-mass 
spectrometry (LC-FLR-QToF-MS) with a 150 ×1.0 mm ID, 1.7 μm Waters BEH Glycan amide 
column. The glycan measurement and the data analysis were performed by Dr. Stefan 
Mittermayr and Dr. Sara Carillo in the NIBRT. 
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4.18 Statistics 
The results were shown as mean  standard deviation (SD). Unpaired t-test was performed 
using Prism 6.0 (GraphPad Software Inc., USA). A p value less than 0.05 was considered 
statistically significant. The n number shown in the embryonic phenotypes and staining (in situ 
hybridization) indicated the exact numbers of evaluated embryos. The studies of the genomics, 
glucose, lactate, and metabolomics were done using a pool of embryos and the n number 
represented the number of independent batches of pooled embryos collection. 
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5. RESULTS 
5.1 Adpgk expression pattern 
Zebrafish adpgk is located at chromosome 25 and the protein shares 64 % similarity with 
human ADPGK. To understand the function of adpgk in embryonic development, we firstly 
screened adpgk gene expression at different developmental stages using RT-qPCR. The 
embryos were collected from four independent batches during one cell, blastula, gastrulation, 
segmentation, pharyngula and hatching stages as shown in Figure 5.1A [59].  
Our results showed that zebrafish embryos displayed the highest adpgk expression at one cell 
stage. Afterwards, the expression was decreased and remained very low through the whole 
developmental process till 96 hpf examined (Figure 5.1B). The early expression and its 
changes during the mid-blastula transition indicated adpgk functioned as a maternal gene. On 
the contrary, other well characterized hexokinases such as hexokinase 1 (hk1) was expressed 
in a very low level at one cell stage. After the mid-blastula stage, the embryos started 
expressing zygotic hk1 and kept the expression in high levels through the rest of the 
developmental process (Figure 5.1C). According to the low expression of adpgk after the mid-
blastula stage, we hypothesized a role of adpgk in fine-tuning glucose metabolism in the 
embryonic development. 
Furthermore, we investigated the specific embryonic expression of adpgk by the in situ 
hybridization method. During the blastula stage, zebrafish embryos showed ubiquitous adpgk 
expression and during the gastrulation stage, embryos expressed adpgk at the dorsal side of 
the body. Adpgk was expressed highly in the notochord during the segmentation stage and 
afterwards, un-specifically in the whole body in the pharyngula stage (Figure 5.1D). Therefore, 
adpgk could play a role in the embryonic body patterning due to its dorsal and notochord 
expression in the embryos. 
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Figure 5.1 Adpgk is a maternal gene with high expression at one cell stage. (A) Zebrafish 
embryos were collected at one cell, blastula, gastrulation, segmentation, pharyngula and 
hatching stages [59] for the screening of adpgk expression using RT-qPCR. (B) The 
embryos showed the highest adpgk expression at one cell stage. The expression decreased 
after mid-blastula and remained low till 96 hpf tested (n=4). (C) Hk1 was expressed very low 
at one cell stage and highly expressed after mid-blastula stage (n=4). (D) In the embryonic 
patterning, adpgk was expressed ubiquitously in the embryos during the blastula stage and 
was expressed at the dorsal side of the body during the gastrulation stage. During the 
segmentation stage, adpgk was expressed highly in the notochord; afterwards, un-
specifically in the whole body in the pharyngula stage. The gene expression was measured 
from 4 independent batches of pooled embryos.  
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5.2 Establishment of loss-of-function adpgk zebrafish model  
5.2.1 CRISPR-mediated adpgk mutants 
To characterize the function of adpgk, we next aimed to establish the loss-of-function zebrafish 
models using the CRISPR/Cas9 system and the anti-sense morpholino knockdown. 
In the CRISPR/Cas9 system, we designed and injected two sgRNAs together with Cas9 into 
the zebrafish embryos at one cell stage. After the embryos had grown, the fins of the adult 
zebrafish were then clipped for genotyping. Scheme of the experimental design was shown in 
Figure 5.2.1A.  
Three founders out of ten zebrafish were identified and further out-crossed with the wild type 
zebrafish. At the crossed-out F1 generation, 6 different types of heterozygous mutations were 
identified among 120 zebrafish. However, due to the imbalanced numbers of male and female 
zebrafish carrying the same heterozygous mutations, we were only able to mate two pairs of 
CRISPR heterozygous-mutated zebrafish (deletion at 24914-24919 and deletion at 24916-
24921) (Figure 5.2.1B). In the F2 generation, although we did not genotype the embryos, the 
surviving zebrafish did not show any prominent phenotypes. We postulated that the 
homozygous adpgk mutations could be lethal or the mutants showed false negative phenotype 
due to the compensatory effect [121]. Since the false negative phenotype has only been 
observed in CRISPR but not morpholino method [121]; plus, the mating, genotyping and raising 
of the CRISPR mutants are time-consuming processes, we decided to focus on using 
morpholino-mediated knockdown strategy to address the function of adpgk in this study. 
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Figure 5.2.1 The establishment of CRISPR mediated loss of function zebrafish model. (A) 
Scheme of the experimental design. (B) The genotypes of the two CRISPR heterozygous 
mutants used for further mating. 
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5.2.2 Morpholinos-mediated adpgk knockdown 
Antisense morpholinos are the most widely used gene knockdown (KD) tool in zebrafish model. 
Morpholinos can either block the splicing process of pre-mRNA or the translation by targeting 
the start codon to interfere the proper protein synthesis [122].  
In the study, we used two morpholinos for the gene knockdown purpose, one splice-blocking 
targeting exon 2 (MO1 for KD1) and one translation-blocking (MO2 for KD2) morpholinos 
(Figure 5.2.2A). MO1 targeted the boundary of adpgk exon 2 and intron 2, and was predicted 
to create a 275-nucleotide-long exon excision. We designed the genotyping primers at the 
exon 1 and 3 with expected full size of 512 base pair (bp); if MO1 functioned well, it would 
create a truncated size of 237 bp adpgk. Our genotyping results from pooled embryos showed 
that both the wild type (WT) and MO1-injected group of embryos (KD1) had the 512-bp 
fragments. The KD1 embryos additionally showed a small fragment around the size of 200-
300 bp, indicating the partial knockdown of adpgk in the KD1 embryos (Figure 5.2.2B). In 
addition, we designed primers targeting exon 2 and exon 3 junctions to further confirm the 
exon excision in the KD1 embryos. The RT-qPCR results showed a more than 2 hold change 
decrease of adpgk mRNA (p<0.005, n=6, compared to the WT) in the KD1 embryos (Figure 
5.2.2C).  
Furthermore, we studied the knockdown efficiency of the morpholino at the protein levels. Both 
MO1 and MO2-injected embryos had decreased adpgk protein at the injection concentration 
of 200 μM and 300 μM, compared to the WT or morpholino control-injected (CO) group (Figure 
5.2.2D). Therefore, we showed the good adpgk knockdown efficiency in the KD1 and KD2 
embryos on genomic and protein levels, and successfully established the morpholino-based 
adpgk loss-of-function zebrafish model in our study.  
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Figure 5.2.2 Adpgk knockdown by morpholino based method. (A) The principles of the 
adpgk morpholinos used in the study. (B) The pooled of WT embryos showed a full size of 
512 bp adpgk while the KD1 embryos had an additional 237-bp fragment (a truncated 
adpgk). (C) For the quantitive adpgk mRNA measurement, the primers were designed at the 
exon 1 and 2 junction. The KD1 embryos showed significantly decreased adpgk expression 
(p<0.005; n=6), compared to the WT. (D) Both KD1 and KD2 embryos had significantly 
decreased adpgk protein (as indicated by the arrow) at the injection concentration of 200 μM 
and 300 μM, compared to the WT or CO group. The embryos for the measurement were 
collected from 6 independent batches. Unpaired t-test was performed with p value less than 
0.05 considered as statistically significant.  
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5.3 Phenotypes of the adpgk knockdown embryos 
5.3.1. Body and somite phenotypes 
The short body axis  
After establishing adpgk loss-of-function model, we examined the phenotype of the adpgk 
knockdown embryos. The KD1 embryos developed short body axis (Figure 5.3.1A and 5.3.1B). 
The lethality and severity of the phenotype was dependent on the concentration of injected 
morpholino. The lethality was 17 % (n=34), 38 % (n=50) and 43 % (n=17) at  injection 
concentration of 150 μM, 250 μM and 300 μM, respectively (Figure 5.3.1C). At 150 μM, 9 % 
(n=34) of the KD1 embryos showed dorsalized body (severe) while 91 % of the KD1 embryos 
did not show prominent body phenotype. At 250 μM, 47 % (n=132) of the KD1 embryos showed 
short body axis (mild) and 17 % (n=132) of the embryos had the severe dorsalized body 
phenotype. When the injection concentration increased to 300 μM, the percentage of KD1 
embryos showed severe phenotype increased to 38 % (n=108) while the mild short body 
phenotype decreased to 15 % (n=108). (Figure 5.3.1D) Based on the percentage of the 
phenotype and lethality, we selected and focused on injecting 300 μM of morpholino to the 
embryos in the following experiments.  
Deformed somitogenesis 
It has been shown that adpgk is expressed in the muscle and heart of the adult zebrafish [123]. 
Due to the dorsalized body phenotype, we wondered whether adpgk deficiency affected the 
somitogenesis of the embryos. Wnt11 is expressed in the embryonic myotome at 25 hpf [124]. 
The result from the in situ hybridization showed that the WT embryos had bilateral and 
uniformed wnt11 patterning while the KD1 embryos showed asymmetric and irregular wnt11 
staining. In accordance with the dorsalized body phenotype, the KD1 embryos also showed 
the deformed somiogenesis. (Figure 5.3.1E) 
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Figure 5.3.1 Short body axis and deformed somitogenesis in the adpgk knockdown 
embryos. (A-B) At 60 hpf, the lateral view and dorsal view of the embryos showed the shorter 
and/or dorsalized body in the KD1 embryos, compared to the CO and WT. (C) The lethality 
of the KD1 embryos was 17 % (n=34), 38 % (n=50) and 43 % (n=17) at the injection 
concentration of 150 μM, 250 μM and 300 μM, respectively. (D) The percentage of the KD1 
embryos showing dorsalized (severe) phenotype increased from 9 % (n=34), 17 % (n=132) 
to 38 % (n=108) at the injection concentration of 150 μM, 250 μM and 300 μM, respectively. 
The mild phenotype decreased from 47 % (n=132) at the injection concentration of 250 μM 
to 15 % (n=108) at 300 μM. (E) The KD1 embryos showed deformed somitogenesis, 
indicated by the asymmetric and irregular wnt 11 staining, compared to the WT. 
 
 
 
 
 
 
RESULTS 
46 
 
5.3.2 Eye, cardiovascular system and hematopoiesis phenotypes 
Deformed eye development 
In addition to the short body and somitogenesis phenotypes, the KD1 embryos showed less 
pigmentation in the eyes, compared to the WT and CO. The eyes of the KD1 embryos were 
also not well separated to the lateral side. Overall, 37 % (n=54) of the KD1 embryos had an 
impaired eye development while none of the WT (n=106) and CO (n=66) embryos had the eye 
phenotypes (Figure 5.3.2A).  
 
Heart malformation 
Since adpgk is expressed in the heart of the adult zebrafish [123], we injected MO1 to the 
embryos of the transgenic zebrafish line Tg(myl7:GFP), labeling myosin light chain 7 (myl7) 
with green fluorescence (GFP) to observe the morphological change of the heart development. 
Thirty-seven percent of the KD1 embryos (n=91) exhibited the normal heart morphology while 
4 % (n=91) showed the normal heart shape but reversed position of the atrium and ventricle 
(reversed heart looping). In addition, 18 % (n=91) of the KD1 embryos exhibited the correct 
heart looping but tubular heart shape while 41 % (n=91) of the embryos showed reversed heart 
looping and tubular heart shape. (Figure 5.3.2B).  
 
Dysregulated vasculature and hematopoiesis 
Human ADPGK is highly expressed in the immune cells [52]. Accordingly, to understand 
whether adpgk plays a role in hematopoietic cells, we knockdown adpgk in the Tg(kdrl:GFP, 
gata1:dsRed) and Tg(pU.1:dsRed) transgenic zebrafish lines. When vascular endothelial 
growth factor receptor kdr-like (kdrl) and gata binding protein1 (gata1) are expressed, the 
Tg(kdrl:GFP, gata1:dsRed) zebrafish has the highlighted vasculature in GFP and erythroid 
lineage cells in dsRed. Additionally, the Tg(pU.1:dsRed) zebrafish has the dsRed-labeled 
myeloid lineage cells when pU.1 is expressed.  
Eighty-seven percent of the Tg(kdrl:GFP, gata1:dsRed) KD1 embryos (n=23) developed 
irregular vasculature and reduced erythrocyte synthesis (Fig. 5.3.2C). The Tg(pU.1:dsRed) 
KD1 embryos showed reduced numbers of myeloid lineage cells, compared to the WT (Figure 
5.3.2D). In addition, the KD1 embryos also showed reduced expression of primitive and 
definitive hematopoiesis marker, runt-related transcription factor (runx1) [125], suggesting the 
malformation of the myeloid development (Figure 5.3.2E).  
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Figure 5.3.2 The malformation of eye, cardiovascular system and hematopoiesis in the KD1 
embryos. (A) Thirty-seven percent (n=54) of the KD1 embryos had impaired eye 
development. (B) Thirty-seven percent of the KD1 embryos (n=91) exhibited the normal 
heart morphology while 4 % (n=91) of the embryos showed the normal heart shape but 
reversed heart looping. Eighteen percent of the KD1 embryos exhibited the correct heart 
looping but tubular heart shape while 41 % (n=91) of the embryos showed reversed heart 
looping and tubular heart shape. (C) Eighty-seven percent (n=23) of the Tg(kdrl:GFP, 
gata1:dsRed) KD1 embryos showed irregular vasculature and improper erythroid cell 
lineage development. (D) The Tg(pU.1:dsRed) KD1 embryos showed impaired development 
of the myeloid lineage cells. (E) The dysregulated definitive hematopoiesis indicated by the 
in situ hybridization of runx1 staining in the KD1 embryos. 
myl7: myosin light chain; kdrl: vascular endothelial growth factor receptor kdr-like; gata1: 
gata binding factor 1 (erythroid transcription factor); pU.1: Sp1 myeloid transcription factor; 
runx1: runt-related transcription factor. 
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5.4 Confirmation of the adpgk KD phenotype 
There are debates of using morpholinos [126]; however, many studies highlight that 
morpholino based research is reliable when proper experimental design and control are used 
[122, 127]. Accordingly, we used three different strategies including overexpression 
experiments, rescue experiments and an additional morpholino (translation-blocking 
morpholino) to confirm the specificity of the KD1 phenotypes.  
First of all, we performed the overexpression experiments since studies indicate that 
overexpression and knockdown of the gene of interest in zebrafish usually create the same 
phenotype [122]. We generated and injected zebrafish or human adpgk mRNA to overexpress 
adpgk in the WT embryos. WT embryos injected with high amounts of zebrafish (600 μM) (22 
%, n=45) or human adpgk mRNA (700 μM) (40 %, n=67) showed a dorsalized body phenotype, 
which was highly similar to the KD1 embryos (Figure 5.4A).  
Next, we used the “rescue” approach to confirm the specificity of the morpholinos (Figure 5.4B). 
We generated zebrafish adpgk mRNA and injected it with MO1 to the embryos to evaluate 
whether the phenotype could be rescued if there were proper adpgk. Our results showed that 
injecting 150 ng/dL of zebrafish adpgk mRNA to KD1 embryos partially rescued the 
short/dorsalized body axis. In the MO1-injected group, 64 % (n=47) percent of the KD1 
embryos showed the short/dorsalized body phenotype. In the MO1 plus zebrafish adpgk 
mRNA injected-group, 59 % (n=76) of the KD1 embryos showed rescue effect (the percentage 
reduced to 41 % of the KD1 embryos showed the phnotype) (Figure 5.4C).  
Last, we confirmed the results of the KD1 embryos using translation blocking morpholino. The 
KD2 embryos showed slightly short body and irregular somite (Figure 5.4D). However, the 
KD2 embryos did not show the phenotypes of the cardiovascular system and hematopoiesis, 
indicating these phenotypes might be secondary effect resulting from the severe dorsalized 
body development. Furthermore, we performed the rescue experiments in the KD2 embryos 
using human ADPGK mRNA since the mRNA sequence used for the rescue experiments 
cannot contain the morpholino target sequence. Our results showed that injecting 100 ng/dL 
of human ADPGK mRNA could also partially rescue the short body phenotype. In the MO2 
injected group, 66 % (n=41) of the KD2 embryos showed the short body. In the group of MO2 
co-injecting with human ADPGK mRNA, 60 % (n=45) of the embryos had the rescue effect 
(Figure 5.4D). To increase to rescue efficiency, we attempted to increase the concentration of 
the injected zebrafish or human adpgk mRNA. However, increasing the concentration could 
not reach the complete rescue but increase the lethality of the KD embryos (Table 5.1). It has 
been shown that rescue experiments seldom results in true wild type and it may only be partial 
RESULTS 
49 
 
due to the injected mRNA expression is generally mosaic and/or the expressed protein may 
last not long enough [128-130].  
Overall, the three different applied strategies suggested the good specificity of the dorsalized 
body phenotype in adpgk deficiency; therefore, we focused on investigating how adpgk 
deficiency led to the short body phenotype. It was also worth noting that morpholino control 
(CO) embryos did not show any phenotype. Thereby, we skip the CO injection for some 
experiments to save the injection time and increase the injection quality. We performed the 
following studies based on the splice blocking morpholino (for KD1) and used translation 
blocking morpholino (for KD2) for the confirmatory experiments. 
 
 
Table 5.1 Summary of adpgk mRNA rescue_ correlation between the injected concentration 
and lethality 
 
Genotype Zebrafish adpgk mRNA (ng/μL) Lethality (%) n number 
KD1 - 40 414 
KD1 100 49 51 
KD1 150 39 312 
KD1 300 20 15 
KD1 500 80 76 
KD1 600 77 123 
Genotype Human ADPGK mRNA (ng/μL) Lethality (%) n number 
KD2 - 42 418 
KD2 100 43 359 
KD2 200 29 72 
KD2 300 77 52 
KD2 500 70 50 
KD2 700 65 79 
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Figure 5.4 Confirmation of the specificity of the short body phenotype in adpgk deficiency. 
(A) Twenty-two percent (n=45) of the embryos with zebrafish adpgk overexpression and 40 
% (n=67) of the embryos with human ADPGK overexpression showed dorsalized body, 
which were highly similar to the KD1 embryos. (B) Scheme of the rescue experiments. (C) 
Co-injecting 150 ng/dL of the synthetic zebrafish adpgk mRNA with splice blocking 
morpholino to the embryos partially rescued the short/dorsalized body axis in the KD1 
embryos. (D) The KD2 embryos showed short body and irregular somite. Co-injecting 100 
ng/dL of the human ADPGK mRNA partially rescued the phenotype in the KD2 embryos. 
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5.5 Defected extension during gastrulation in embryos with adpgk deficiency 
Embryonic body patterning is organized in the early developmental process. During the 
gastrulation stage, convergent extension determines the body length [131, 132]. To investigate 
whether the KD1 embryos showed defected convergent extension during the gastrulation, the 
prechordal plate, anterior edge of the neural plate and the developing notochord of the bud-
stage-embryo (10 hpf) were stained by in situ hybridization using hgg1, dlx3 and ntl probe, 
respectively. Compared to the WT, the KD1 embryos had defected extension (p<0.05, n=59), 
indicated by the shorter distance between prechordal plate and the developing notochord 
(Figure 5.5A).  
Since convergent extension is the process of collective cell movement and small Rho-
GTPases proteins-related signaling pathway mediates the cell migration and intercalation 
(Figure 5.5B) [133], we next measured the level of Rac1/2/3 to understand whether the cell 
migration was dysregulated. Compared to the WT, the KD1 and KD2 embryos at 22 hpf 
showed decreased Rac1/2/3 (p<0.05 in the KD1; p=0.0549 in the KD2, n=3), indicating the 
involvement of dysregulated Rho-GTPase-related signaling pathway in adpgk deficiency. (Fig 
5.5C)  
Rac1/2/3 is regulated by the wnt signaling and the wnt signaling pathways has been shown to 
be highly related to convergent extension [76, 77]. Accordingly, to investigate whether there 
were dysregulated wnt signals leading to the malformation of convergent extension, we 
attempted to rescue the phenotype with different synthetic dishevelled (dsh) mRNA, the key 
component of wnt signaling pathway including dsh (general dsh), dsh_ΔC (dsh with domain 
specifically activates canonical wnt) and dsh_ΔN (dsh with domain specifically activates 
noncanonical wnt) [134]. However, increasing dsh expression in the KD1 embryos could not 
rescue the short/dorsalized body phenotype. Table 5.2 showed that 70 % (n=46) of the KD1 
embryos developed short/dorsalized body; however, when co-injecting MO1 with 200 ng/dL of 
dsh, dsh_ΔC or dsh_ΔN mRNA, 65 % (n=121), 58 % (n=24) or 69 % (n=32) of the embryos 
still exhibited the short/dorsalized body, respectively. 
Overall, the insufficiency of the dsh mRNA rescue experiments suggested that wnt signals 
might not be the main factors causing the short body axis in adpgk deficiency or the effects 
were not on genomic levels.  
 
 
 
RESULTS 
52 
 
Table 5.2 Summary of dishevelled mRNA rescue 
Genotype mRNA injected Conc.(ng/μL) Phenotype (%) n number 
KD1 - - 70% 46 
KD1 Dsh 100 66% 83 
KD1 Dsh 200 65% 121 
WT Dsh 200 0% 5 
KD1 Dsh_ΔC 100 70% 89 
KD1 Dsh_ΔC 200 58% 24 
WT Dsh_ΔC 200 0% 5 
KD1 Dsh_ΔN 100 75% 52 
KD1 Dsh_ΔN 200 69% 32 
WT Dsh_ΔN 200 13% 8 
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Figure 5.5 Defected extension during the gastrulation with reduced GTPase protein in adpgk 
deficiency. (A) The KD1 embryos had shorter extension, indicated by the short length 
between prechordal plate (hgg1) and nortochord (ntl) (p<0.05 n=59 embryos), compared to 
the WT. (B) Scheme of the GTPase proteins-related signaling pathway. (C) Compared to 
the WT, KD1 (p<0.05, n=3) and KD2 embryos (p=0.0549, n=3) showed decreased Rac1/2/3 
protein level. The n number shown in the in situ hybridization indicated the exact numbers 
of evaluated embryos. The levels of Rac1/2/3 were measured from three independent 
batches of pooled embryos. Unpaired t-test was performed with p value less than 0.05 
considered as statistically significant.  
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5.6 Unchanged gene expression of the developmental signaling pathways in embryos 
with adpgk deficiency  
In addition to wnt, hedgehog (hh) signaling pathway regulates the ciliogenesis and determines 
the body patterning. In hh signaling pathway, the binding of shh to its receptor, patch1 (protein 
patched homolog 1) activates the downstream transcription factor, gli1 (glioma-associated 
oncogene homolog); furthermore, gli1 targets to the genes involving in regulating cell 
proliferation, apoptosis and angiogenesis [135]. Interestingly, inhibiting hh signaling in 
zebrafish has been shown also leads to the abnormal cardiomyocyte, retina and notochord 
development [136]. Accordingly, we collected embryos at the gastrulation stage and examined 
whether hh signaling was impaired by measuring the expression of shh-related genes. 
However, our RT-qPCR results revealed the unchanged shha (n=9), patch1 (n=5) and gli1 
(n=6) expression in the KD1 embryos, compared to the WT (Figure 5.6A).  
Alternatively, due to the dorsal embryonic expression of adpgk, we investigated whether there 
were changes of the dorsal organizer genes in adpgk deficiency. For instance, chordin 
regulates dorsal-ventral patterning in the early embryonic development [137]. Chordin and 
sox17 are required for the formation of Kupffer’s vesicle and the determination of left-right 
asymmetry in zebrafish. Also, it has been shown that knockdown of sox 17 in zebrafish results 
in slightly shortened body axis, heart edema and cell death phenotypes [138]. However, we 
did not observe significant changes of the chordin and sox17 embryonic patterning in adpgk 
deficiency from the in situ hybridization staining (Figure 5.6B).  
Since several developmental signaling pathways orchestrate the body patterning and 
embryonic development [62], to further understand whether there was a dysregulation of the 
main developmental pathway in the KD1 embryos during the gastrulation, we used a “signal 
transduction PathwayFinder PCR array (Qiagen, Hilden, Germany)” for a broad screening. The 
array includes genes involving in the tgfβ, wnt, nf-κb, jak/stat, notch, hedgehog, ppar, oxidative 
stress, hypoxia and p53 signaling pathways (Table 5.3). Surprisingly, the KD1 embryos 
showed only few significant changes of the gene expression in the screened signaling 
pathways, compared to the WT. The volcano plot (Figure 5.6C) summarized the fold changes 
and p values of the screened genes. The identified promising target genes were wnt6, carbonic 
anhydrase9 (ca9), inhibitor of dna binding1 (id1), NAD(P)H dehydrogenase, quinone 1 (nqo1) 
and bmp4 as well as cell death and cell cycle related genes. Overall, based on the mRNA 
screening, it seemed that the main developmental signaling pathways were not strongly 
affected in the KD1 embryos. Mechanisms other than the altered developmental signaling 
seemed to be the culprit for causing the phenotypes in adpgk deficienc 
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Table 5.3 List of genes in the “signal transduction PathwayFinder PCR array”. 
Pathways Genes 
TGFβ atf4b1, atf4b2, emp1, herpud1, ifrd1, myca, mycb, nfixa, tnfsf10. 
WNT  
axin2, ccnd1, ccnd2a, dab2, fosl1a, ppardb, wisp1a, wisp1b, wnt2bb, 
wnt5a. 
NFκB  bcl2l1, birc2, stat1a 
JAK/STAT  bcl2l1, cebpd, gata3, irf1a, mcl1a, mcl1b, lrg1, socs3a, socs3b, stat1a 
p53 
baxa, bbc3, btg2, cdkn1a, egfra, fas, gadd45aa, gadd45ab, 
gadd45ba, pcna, rb1 
Notch  her6, hey1, hey2, heyl, id1, jag1b, lfng, notch1b 
Hedgehog  bcl2, bmp2b, bmp4, wnt6, ptch1, wnt1, wnt3a 
PPAR  acsl3a, acsl3b, acsl4a, acsl5, cpt2, fabp1a, sorbs1, slc27a4 
Oxidative Stress fth1a, fth1b, gclc, gclm, hmox1a, nqo1, sqstm1, txnrd1, gsr  
Hypoxia 
arnt, ca9, csf1a, csf1b, epo, ldha, adm, serpine1, slc2a1a, slc2a1b, 
vegfab 
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Figure 5.6 Unchanged gene expressions of the developmental signaling pathways in adpgk 
deficiency. (A) Compared to the WT, the KD1 embryos showed unchanged expression of 
shha, ptch1 and gli1 (n ≥ 5). (B) In situ hybridization showed that adpgk knockdown did not 
affect the patterning of organizer genes, chordin (n=12 embryos) and sox17 (n=15 embryos). 
(C) The volcano plot showed the correlation between the fold change (x-axis) and the p 
value (y-axis) of the gene expression from the signal transduction PathwayFinder PCR array. 
The array identified significant changes of ca9, nqo1 and bmp4, and a more than 2 fold-
decreased wnt6a in the KD1 embryos (n=3). The n number shown in the in situ hybridization 
indicated the exact numbers of evaluated embryos. The RT-qPCR results were done from 
at least three independent batches of pooled embryos. Unpaired t-test was performed with 
p value less than 0.05 considered as statistically significant. 
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5.7 Increased apoptosis in adpgk knockdown embryos 
The results from the signal transduction PathwayFinder PCR array showed, albeit high 
variation, changes of the apoptosis-related and the cell cycle-regulating molecules in adpgk 
deficiency. Since the embryonic development is a coordinated process between different cell 
behaviors such as the cell proliferation and cell death, we sought whether adpgk knockdown 
exhibited increased apoptosis, which led to the short body phenotype. Accordingly, we 
investigated the cell death of embryos at the 24 hpf by Acridine Orange and TUNEL staining.  
Acridine orange is a nucleic acid-selective fluorescent dye. It stains DNA and presents a 
condensed green fluorescence in the dead cells. [139]  Acridine Orange staining showed 
increased dead cells through the whole body of the 22 hpf KD1 embryos, while the WT had 
only few patches of the condensed green fluorescent staining indicative of apoptosis (Figure 
5.7A).  
TUNEL staining detects double-strand DNA breaks (green fluorescence), a hallmark of 
apoptosis. In accordance with the Acridine Orange staining, TUNEL assay showed increased 
numbers of apoptotic cells in both 22 hpf KD1 and KD2 embryos, compared to the WT. (Figure 
5.7B) The irregular shape of the body part in the KD embryos coincided with the area of 
increased apoptotic cells, implying apoptosis resulted in the body phenotype. 
To confirm the increased apoptosis, we collected embryos at the gastrulation stage and 
measured the expression of the apoptosis-related genes using RT-qPCR. In line with the 
increased apoptosis, albeit unchanged bcl expression, the KD1 embryos showed induced 
expression of the pro-apoptotic factor, bbc3 (p<0.05, n ≥ 5) and reduced expression of the anti-
apoptotic gene, bcl2l (p<0.005, n ≥ 5), compared to the WT. The reduced bcl2l expression 
could also be rescued when injecting synthetic zebrafish adpgk mRNA in the KD1 embryos 
(p<0.05, n ≥ 5, compared to the KD1) (Figure 5.7C).  
Therefore, the results overall showed that adpgk deficiency induced apoptosis, which could 
possibly lead to the crippled body phenotype.  
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Fig. 5.7 Increased apoptosis in adpgk deficiency. (A) Compared to the WT, the KD1 embryos 
had more dead cells, indicated by the increase of the condensed green fluorescent in 
Acridine Orange staining. (B) The result from TUNEL assay showed increased apoptotic 
cells in the KD1 and KD2 embryos, compared to the WT. (C) The KD1 embryos had activated 
bbc3 (p<0.05) and reduced bcl2l (p<0.005) expression, compared to the WT. The reduction 
of bcl2l expression could be rescued with adpgk mRNA (p<0.05, compared to KD1). The 
embryos were collected from at least 5 independent batches. Unpaired t-test was performed 
with p value less than 0.05 considered as statistically significant.  
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5.8 The activated cell cycle checkpoints in adpgk knockdown embryos 
Cell death and cell proliferation are regulated by the cell cycle checkpoints. Cells with DNA 
damage or under certain stress activate cell cycle checkpoints. Generally, cells undergo 
quiescence or apoptosis when the damages are unrepairable [140]. 
Thus, to investigate whether adpgk deficiency triggered the activation of the cell cycle 
checkpoints and led to apoptosis, we screened the expression of cell cycle-related genes 
including cyclin-dependent kinase inhibitor 1A (cdkn1a; p21), mycb, growth arrest and DNA-
damage-inducible, alpha, a (gadd45aa) and rb1 in the embryos during the gastrulation stage 
using RT-qPCR.  
Consistent with the increased apoptosis, the cell cycle checkpoints were activated in the KD1 
embryos. The KD1 embryos had increased expression of the cell cycle checkpoint genes, 
cdkn1a (p<0.005, n ≥ 5) and gadd45aa (p<0.005, n ≥ 5), compared to the WT. In addition, the 
KD1 embryos also showed slightly increased mycb expression (p=0.06, n ≥ 5) but unchanged 
rb1 expression, compared to the WT. Notably, the increased expression of cdkn1a could also 
be reduced when supplying synthetic zebrafish adpgk mRNA in the KD1 embryos (p<0.05, n 
≥ 5, compared to the KD1) (Figure 5.8A), indicating the expression of cdkn1a was highly 
correlated to adpgk.  
Since p53 up-regulation is one of the most common mechanisms triggering the activation of 
cdkn1a and further promoting cell cycle arrest and cell death [141], we thought the activation 
of p53 led to the cell cycle arrest and cell death in adpgk deficiency. According to the 
hypothesis, we knocked down p53 expression by MO-p53 in the KD1 embryos and evaluated 
whether decreasing p53 expression could rescue the phenotype. Our results showed that 73 
% (n=91) of the KD1 embryos had the short/dorsalized body phenotypes; however, the 
percentage increased to 92 % (n=72) when suppressing p53 expression in the KD1 embryos 
(Figure 5.8B). Consistently, the exacerbation outcome was also observed in the KD2 embryos. 
Seventy-two percent (n=152) of the KD2 embryos had the short/dorsalized body phenotypes 
and the percentage increased to 89 % (n=84) when suppressing p53 expression in the KD2 
embryos  
Overall, the insufficiency of p53 rescue experiments suggested that the cell cycle arrest and 
apoptosis in embryos with adpgk deficiency was through a p53-independent pathway. 
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Figure 5.8 Activated cell cycle checkpoints in adpgk deficiency. (A) The RT-qPCR results 
revealed the increased expression of the cell cycle checkpoint genes, cdkn1a (p<0.005, n ≥ 
5) and gadd45aa (p<0.005, n ≥ 5) in the KD1 embryos, compared to the WT. The increased 
cdkn1a could also be rescued in the KD1 embryos (p<0.05, compared to the KD1) The KD1 
embryos also showed slightly increased mycb (p=0.065, n ≥ 5) and unchanged rb1. (B) 
Reducing p53 in adpgk deficiency could not rescue the short/doralized body phenotype. 
Seventy-three percent (n=91) of the KD1 embryos showed short/dorsalized body, while 
knockdown p53 in the KD1 embryos increased the percentage of embryos with the 
phenotypes increased to 92 % (n=72). Compared to 72 % (n=152) of the KD2 embryos 
showed short body axis, the percentage of embryos with the phenotypes increased to 89 % 
(n=84) when suppressing p53 expression. The gene expressions were investigated using 
embryos collected from more than 5 independent batches. Unpaired t-test was performed 
with p value less than 0.05 considered as statistically significant.  
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5.9 The disturbed glucose homeostasis and pH balance in embryos with adpgk 
deficiency 
Growing body of evidences have suggested that the cell cycle progression and cell death are 
controlled by the nutrient status, and the metabolic disturbance eventually leads to the cell 
death. [142, 143] Thereby, we hypothesized the activated cell cycle arrest and cell death were 
resulted from the altered glucose homeostasis in adpgk deficiency.  
According to our speculation, we first measured the free glucose level of the embryos. Our 
results showed that both KD1 (0.387±0.0259 mmol/g, p<0.01, n=6) and KD2 embryos 
(0.306±0.0216 mmol/g, p<0.005, n=6) had significantly decreased free glucose, compared to 
the WT (0.533±0.0372 mmol/g) (Figure 5.9A). Intriguingly, the decreased glucose did not alter 
the energy status in the embryos. Compared to the WT, the KD1 embryos showed unchanged 
ATP, ADP and AMP (n=5) (Figure 5.9B). Thus, it seemed that the embryonic cells in adpgk 
deficiency had increased glucose usage for maintaining the energy level.  
Since the increased glucose uptake and lactate production are the hallmarks of cells employ 
aerobic glycolysis (Warburg effect) to maintain the sufficient energy generation[7], we 
wondered whether adpgk knockdown benefited from the Warburg phenotype. Accordingly, we 
measured the gene expression of the glucose transporter and hexokinases including solute 
carrier family 2 member 1 (slc2a1a), hk1 and hk4, and the level of lactate and pyruvate. Indeed, 
we found the increased hk1 expression (p<0.01, n≥5), despite of the unchanged glucose 
transporter (slc2a1a) and hk4 expression in the embryos at the gastrulation stage (Figure 5.9C). 
However, adpgk deficiency exhibited reduced lactate-to-pyruvate ratio (lactate/pyruvate). The 
KD1 embryos showed a 1.59-fold decreased lactate/pyruvate (72.31 ± 14.120 in the WT vs. 
45.59 ± 5.346 in the KD1, p=0.076, n=3) and also the KD2 embryos had a 1.81-fold decreased 
lactate/pyruvate (72.31 ± 14.120 in the WT vs. 40.00 ± 7.329 in the KD2, p=0.056, n=3) (Figure 
5.9D). Thus, the result of decreased lactate/pyruvate suggested an altered glucose 
metabolism (anti-Warburg phenotype) in adpgk deficiency. 
In addition to the energy generation, the level of lactate influences the acid and base status 
[144]. Interestingly, the results from the RT-qPCR array also suggested the change of ca9 in 
the KD1 embryos. Ca9 maintains intracellular and extracellular pH and is increased in 
response to the accumulation of intracellular lactate [145]. Consistent with the decreased 
lactate, we confirmed that the KD1 embryos exhibited a significant decrease of ca9 expression 
(p<0.005, compared to the WT, n≥5). The decreased expression of ca9 could be rescued when 
supplying adpgk mRNA (p<0.005, compared to the KD1, n≥5) (Figure 5.9E), suggesting the 
high correlation between ca9 and adpgk expression. In concert with the decreased 
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lactate/pyruvate, the decreased ca9 expression also indicated a perturbed acid-basic 
homeostasis in adpgk deficiency. Overall, the altered glucose homeostasis and pH balance 
could induce cell death in adpgk deficiency. 
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Figure 5.9 An altered glucose metabolism and pH balance in adpgk deficiency. (A) Both 
KD1 (0.387±0.0259, p<0.01, n=6) and KD2 (0.306±0.0216, p<0.005, n=6) embryos showed 
significantly decreased free glucose, compared to the WT (0.533±0.0372) (B) The level of 
ATP, ADP and AMP was not changed in the KD1 embryos. (C) The KD1 embryos showed 
increased expression of hk1 (p<0.01, n≥5) but unchanged hk4 and slc2a1a, compared to 
the WT. (D) Decreased lactate to pyruvate ratio in adpgk deficiency. The KD1 embryos 
showed a 1.59-fold decreased lactate/pyruvate (72.31 ± 14.120 in the WT vs. 45.59 ± 5.346 
in the KD1, p=0.076, n=3) and the KD2 embryos had a 1.81-fold decreased lactate/pyruvate 
(72.31 ± 14.120 in the WT vs. 40.00 ± 7.329 in the KD2, p=0.056, n=3). (E) Ca9 expression 
was significantly decreased in the KD1 embryos (p<0.005, compared to the WT, n≥5) and 
the decreased ca9 expression could be rescued when supplying adpgk mRNA (p<0.005, 
compared to KD1, n≥5). The metabolic measurements were carried out using embryos 
collected from at least 3 independent batches while the the gene expression were 
investigated using embryos collected from more than 5 independent batches. Unpaired t-
test was performed with p value less than 0.05 considered as statistically significant.  
The measurement of ATP, ADP and AMP was performed by the Metabolomics Core Facility 
of Heidelberg University. 
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5.10 Increased PPP in adpgk knockdown embryos 
Due to the altered glucose homeostasis, we performed glucose flux studies to understand how 
glucose was metabolized in adpgk deficiency. We first aimed to establish a liquid 
chromatography tandem mass spectrometry (LC-MS/MS) method for measuring the main 
glucose intermediates in the embryos including G6P, FBP, GAP, PEP, PYR, and Ru5P. The 
detailed parameters of the MS/MS were listed in Table 5.4.  
First, we established the standard curves of G6P, FBP, GAP, PEP, PYR and Ru5P from 0.1 
μM to 10 μM with the linearity between 0.98 and 0.99. To test the reliability of the measurement, 
we next spiked the known concentration (1.6 μM, 4 μM and 8 μM) of G6P, FBP, GAP, PEP, 
PYR and Ru5P to the blank matrix and calculated the measured concentration (recovery rate). 
The recovery rate of G6P, FBP, GAP, PEP, PYR and Ru5P at 1.6 μM, 4 μM and 8 μM were 
from 80 % to 119 %, 94 % to 114 %, and 82 % to 104 %, respectively (Table 5.5). The overall 
recovery rates fell into the range between 80% and 120 %, indicating the good reliability of the 
measurement. In addition, we tested the precision of the method by measuring 10 samples 
that had the same concentration. The variation (precision CV %) of G6P, FBP, GAP, PEP, 
PYR and Ru5P measurement were 8.4 %, 7.5 %, 8.1 %, 7.4 %, 7.8 % and 6.2 %, respectively 
(Table 5.5). Therefore, based on the good recovery rate and precision, we successfully 
established the LC-MS/MS method for measuring glucose intermediates.   
Next, we used the established LC-MS/MS method to study glycolytic flux in adpgk deficiency 
(Figure 5.10A). In accordance with the decreased free glucose, the MS/MS results showed 
that KD1 embryos had significantly increased G6P level (2.17 ± 0.098 μmol/g in WT vs. 2.92 
± 0.213 μmol/g in KD1, p<0.01), suggesting an increased glucose consumption.  However, the 
level of FBP and PEP were unchanged. Interestingly, Ru5P, the product of PPP and GAP, the 
metabolite in both glycolysis and PPP were strongly increased. The KD1 embryos showed a 
1.6-fold-increased Ru5P (0.11 ± 0.008 μmol/g in WT vs. 0.18 ± 0.008 μmol/g in KD1, p<0.005) 
and a 2-fold-increased GAP (0.22 ± 0.047 μmol/g in WT vs. 0.45 ± 0.083 μmol/g in KD1, 
p<0.05). 
The increased Ru5P in KD1 embryos could also be reduced when rescuing with zebrafish 
adpgk mRNA (0.18 ± 0.008 μmol/g in KD1 vs. 0.13 ± 0.009 μmol/g in KD1+adpgk, p<0.01) 
(Fig. 5.10B).  Overall, our glycolytic flux study indicated an increased glucose flux to PPP in 
adpgk deficiency.   
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Table 5.4  Tandem mass spectrometry parameters of the targeted glucose intermediates 
Compounds Parent ion (m/z) Daughter ion (m/z) Cone (Volts) Coll energy (eV) 
G6P -258.70 -96.70 -51.00 -14.00 
FBP -338.90 -96.80 -117.00 -21.00 
GAP -168.90 -96.80 -38.00 -8.00 
PEP -166.70 -78.80 -36.00 -13.00 
PYR -86.80 -43.20 -60.00 -8.00 
Ru5P -228.90 -96.70 -46.00 -10.00 
LAC-13C3 -89.90 -44.10 -68.00 -9.00 
 
 
 
Table 5.5  Recovery rate and intra-run imprecision of the measurement 
Compounds Recovery (%) 
1.6 μM 
Recovery (%) 
4 μM 
Recovery (%) 
8 μM 
Imprecision 
(CV %) 
G6P 100 114 104 8.4 
FBP 80 105 82 7.5 
GAP 119 107 103 8.1 
PEP 116 97 99 7.4 
PYR 86 94 82 7.8 
Ru5P 99 114 102 6.2 
 
Glucose-6-Phosphate (G6P), Fructose-1,6-Bisphosphate (FBP), Glyceraldehyde-3-
Phosphate (GAP), Phosphoenylpyruvate (PEP), Ribulose-5-Phosphate (Ru5P), 
Phosphoenylpyruvate (PEP), Pyruvate (PYR) 
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Figure 5.10 Increased glucose flux to PPP in adpgk deficiency. (A) Scheme of the glucose 
flux study. (B) The LC-MS/MS result showed a significant increase of G6P (2.17 ± 0.098 
μmol/g in WT vs. 2.92 ± 0.213 μmol/g in KD1, p<0.01) but unchanged FBP and PEP level. 
KD1 embryos had activated PPP, indicated by increased Ru5P (0.11 ± 0.008 μmol/g in WT 
vs. 0.18 ± 0.008 μmol/g in KD1, p<0.005) and GAP (0.22 ± 0.047 μmol/g in WT vs. 0.45 ± 
0.083 μmol/g in KD1, p<0.05). The increased Ru5P in KD1 embryos could be reduced when 
rescuing with zebrafish adpgk mRNA (0.18 ± 0.008 μmol/g in KD1 vs. 0.13 ± 0.009 μmol/g 
in KD1+adpgk, p<0.01). The measurement were done using embryos collected from more 
than 5 independent batches. Unpaired t-test was performed with p value less than 0.05 
considered as statistically significant.  
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5.11 Altered defense system against ROS in adpgk knockdown embryos 
Next, we sought why adpgk deficiency exhibited the increased glucose flux to PPP. Since the 
main function of the PPP is detoxify ROS [146], and we also observed the increased cell death 
in adpgk deficiency, we first speculated an altered ROS defense system in the adpgk KD 
embryos. Accordingly, we measured the level of NADPH, the downstream product of PPP 
participating in the conversion of GSSG to GSH for the detoxification of ROS. However, our 
results showed unchanged NADPH level in the KD1 embryos (Figure 5.11A) and additionally 
unchanged NADH/NAD+, the indicator of nitrosative stress and GSSG/GSH, the indicator of 
ROS. It was worth noting that despite of the unchanged GSSG/GSH, the KD1 embryos rather 
showed a decrease of total glutathione (127.3 ± 3.033 pmol/embryos in the WT vs. 118.2 ± 
2.520 pmol/embryos in the KD, p<0.05, n=5) (Figure 13A).  
In addition to glutathione, several enzymes and molecules possess anti-oxidant activities.[146, 
147] Because the preliminary data from the “signal transduction PathwayFinder PCR array” 
revealed the possible changes of thioredoxin reductase1 (txnrd1) and NAD(P)H:(quinone-
acceptor) oxidoreductase (nqo1) in adpgk deficiency, we then focused on investigating the 
effect of adpgk on the gene expression of these anti-oxidant enzymes. Our results showed that 
the KD1 embryos had significantly decreased txnrd1 (p<0.005, n ≥ 5) expression, compared 
to the WT. The decreased txnrd1 expression in the KD1 embryos could be partially rescued 
with adpgk mRNA (p=0.062, compared to the KD1 embryos, n ≥ 5) (Figure 5.11B). In addition, 
the expression of nqo1 was also decreased in the KD1 embryos (p<0.005, compared to the 
WT, n ≥ 5) and the decreased expression could be partially rescued when supplying zebrafish 
adpgk mRNA (p=0.067, compared to the KD1, n ≥ 5) (Figure 5.11B). Thereby, the results 
suggested the high correlation of the gene expression between adpgk and the anti-oxidant 
enzymes, txnrd1 and nqo1. Furthermore, the decreased txnrd1 and nqo1 also indicated the 
dysregulation of the defense system against ROS in adpgk deficiency.  
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Figure 5.11 The dysregulation of the defense system against ROS in adpgk deficiency. (A) 
The KD1 embryos showed unchanged NADPH level, NADH/NAD and GSH/GSSG (n=5) but 
decreased total glutathione (127.3 ± 3.033 pmol/embryos in the WT vs. 118.2 ± 2.520 
pmol/embryos in the KD, p<0.05, n=5). (B) The gene expression of the anti-oxidant 
enzymes, txnrd1 (p<0.005, n ≥ 5) and nqo1 (p<0.005, n ≥ 5) were decreased in the KD1 
embryos, compared to the WT. Supplying adpgk mRNA could partially rescued the 
decreased expression of txnrd1 (p=0.062, compared to the KD1, n ≥ 5) and nqo1 (p=0.067, 
compared to the KD1, n ≥ 5).The embryos used for the measurements were collected from 
at least 5 independent batches. Unpaired t-test was performed with p value less than 0.05 
considered as statistically significant.  
The measurement of NADPH, NAD, NADH, and the glutathione was performed by the 
Metabolomics Core Facility of Heidelberg University. 
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5.12 Altered one-carbon metabolism and metabolic disturbance in embryos with adpgk 
deficiency 
Glucose metabolism also provides precursors for the one-carbon metabolism and the 
synthesis of glycans. Thus, we wondered whether the altered glucose homeostasis in adpgk 
deficiency disturbed the one-carbon metabolism and/or hexosamine biosynthesis pathways. 
Accordingly, we first studied the levels of the amino acids and the metabolites involving in the 
one-carbon metabolism. Our metabolic study showed that compared to the WT, the KD1 
embryos had 1.22-fold decreased threonine (17.62 ± 1.451 μmol/g in the WT vs. 14.37 ± 0.717 
μmol/g in KD1, p=0.058, n=3), 1.35-fold decreased glycine (14.60 ± 0.313 μmol/g in WT vs. 
10.78 ± 0.507 μmol/g in KD1, p<0.01, n=3) and 1.25-fold decreased methionine (13.68 ± 1.100 
μmol/g in WT vs. 10.93 ± 0.185 μmol/g in KD1, p<0.05, n=3) (Figure 5.12A). Although the 
levels of SAM, SAH and MTA were not changed, SAM/SAH, the indicator of the methylation 
modification seemed to be increased (p=0.081, n=3) in the KD1 embryos. The increased 
SAM/SAH could be rescued with adpgk mRNA (p<0.01, compared to the KD1, n=3) (Figure 
5.12B) Thereby, these results indicated an altered one-carbon metabolism in adpgk deficiency. 
Furthermore, we investigated whether adpgk deficiency also caused the perturbation of other 
amino acid synthesis since amino acids are crucial for the embryonic development. The KD1 
embryos showed decreased citrulline (0.99 ± 0.058 μmol/g in WT vs. 0.41 ± 0.238 μmol/g in 
KD1, p<0.05), histidine (8.84 ± 0.334 μmol/g in WT vs 7.27 ± 0.394μmol/g in KD1, p<0.05), 
phenylalanine (15.85 ± 0.528 μmol/g in WT vs 11.19 ± 0.414 μmol/g in KD1, p<0.01) and 
tyrosine (21.91 ± 0.732 μmol/g in WT vs. 16.24 ± 1.109 μmol/g in KD1, p<0.05), compared to 
the WT (Figure 5.12C). Interestingly, the metabolic phenotypes reflected the morphological 
phenotypes of the KD1 embryos. Phenylalanine is converted to tyrosine and both involve in 
melanin synthesis [148, 149]. The decreased phenylalanine and tyrosine coincided with the 
reduced pigmentation at the eye region of the KD1 embryos. The decreased glycine also 
correlated to the decrease of total glutathione synthesis in the KD1 embryos. Overall, adpgk 
deficiency showed a disturbed amino acid biosynthesis, which possibly affected the resource 
supply for methylation modification and the overall nutrients requirement for the embryonic 
development. 
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Figure 5.12 The disturbed metabolic network in adpgk deficiency. (A) Altered one-carbon 
metabolism in adpgk deficiency. The KD1 embryos showed 1.22-fold decreased threonine 
(p=0.058, n=3), 1.35-fold decreased glycine (p<0.01, n=3) and 1.25-fold decreased 
methionine (p<0.05, n=3), compared to the WT. (B) Despite of the unchanged SAM, SAH 
and MTA, SAM/SAH seemed to be increased (p=0.081, n=3) in the KD1 embryos and the 
increased SAM/SAH could be rescued with adpgk mRNA (p<0.01, compared to the KD1, 
n=3) (C) The KD1 embryos showed decreased citrulline (0.99 ± 0.058 in WT vs. 0.41 ± 0.238 
in KD1, p<0.05, n=3), histidine (8.84 ± 0.334 in WT vs 7.27 ± 0.394 in KD1, p<0.05, n=3), 
phenylalanine (15.85 ± 0.528 in WT vs 11.19 ± 0.414 in KD1, p<0.01, n=3) and tyrosine 
(21.91 ± 0.732 in WT vs. 16.24 ± 1.109 in KD1, p<0.05, n=3). The measurement was 
performed from the pooled embryos collected from three independent batches. The p value 
less than 0.05 was considered as statistically significant.  
The measurement of SAM, SAH and MTA was performed by the Metabolomics Core Facility 
of Heidelberg University. 
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5.13 Perturbation of glycan synthesis in adpgk knockdown embryos 
Since adpgk is localized in the ER where the glycosylation occurs, we next investigated 
whether the disturbed glucose metabolism also altered glycan synthesis in adpgk deficiency.  
To understand the activity of hexosamine biosynthesis pathway, we extracted the proteins from 
50 embryos and examined the level of GFAT, the rate limiting enzyme. Our preliminary result 
showed that KD1 and KD2 embryos exhibited reduced GFAT, compared to CO (Figure 5.13A). 
It seemed that knockdown of adpgk downregulated hexosamine biosynthesis pathway. 
To investigate the effect of adpgk on protein glycosylation, we next examined the levels of O-
GlcNACylation and glycans by western blots and lectin blots, respectively. From the O-GlcNAc 
blot, the KD1 and KD2 embryos both showed a slight decrease of O-GlcNAc at the proteins 
size between 26 kDa to 55 kDa, compared to the CO (Figure 5.13B). The result suggested that 
in adpgk knockdown embryos, the O-GlcNACylation on the specific proteins were altered.  
Lectins are the carbohydrates-binding proteins. Concanavalin A (ConA) binds to the α-linked 
mannose residues, Sambucus Nigra Lectin (SNA) binds to the sialic acid with α-2,6 attachment 
to the terminal galactose, and Wheat Germ Agglutinin (WGA) binds to the terminal N-
acetylglucosamine or chitobiose [150]. The results from the ConA, SNA and WGA lectin blots 
revealed the different lectin patterns in the KD1 and KD2 embryos (as marked in the box), 
compared to the CO embryos (Figure 5.13C-E). Therefore, these preliminary O-GlcNAc and 
lectins results implied the disturbance of glycan synthesis and the alteration of protein 
glycosylation in adpgk deficiency.  
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Figure 5.13 Disturbed protein glycosylation in adpgk deficiency. (A) Decreased GFAT level 
in the KD1 and KD2 embryos, compared to CO. (B) The KD1 and KD2 embryos showed 
decreased O-GlcNAc patterns at the proteins size between 26 kDa to 55 kDa, compared to 
the CO. (C-E) The ConA, SNA, and WGA lectin blots showed discrete glycan patterns 
(highlighted in the box) between the adpgk knockdown and CO. 
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5.14 Altered N-glycosylation in adpgk knockdown embryos 
To further specifically identify the effects of adpgk deficiency on the protein glycosylation, we 
performed glycomics study focusing on N-glycans in the cooperation with the National Institute 
for Bioprocessing Research and Training (NIBRT), Ireland. The scheme of the glycomics study 
was indicated in the Figure 5.14A. The extracts of the released glycans from a pooled of 200 
embryos were first separated according to the degree of charge by weak anion exchange 
HPLC. Subsequently, the fractions containing different charged glycans were collected and 
digested with a serial of glycosidase enzymes and further separated by the LC-FLR-QTOF-
MS for the identification of glycan structures.  
Our glycomics analysis showed the significant decrease of high mannose glycan in the KD1 
embryos, compared to the WT (Figure 5.14B). The glycans of GlcNAc2 attached with high 
mannose are the precursors of all the N-glycans. Accordingly, the decreased high mannose 
glycan structures suggested a general decrease of N-glycan biosynthesis in adpgk deficiency. 
The detailed information of high mannose-type glycans regarding the charge, structures and 
fold changes were summarized in Table 5.6. Interestingly, several complex- and hybrid-type 
glycans were also decreased in the KD1 embryos (Table 5.7). In particular, 
HexNAc4Hex7Fuc2NeuGc2 was decreased with a 5.85 fold change, and GlcNAc3Hex6 
(GlcNAc2Man5GlcNAcGal) was decreased with a 1.6 fold change (as marked in the boxes) in 
the KD1 embryos, compared to the WT (Figure 5.14C). Overall, adpgk deficiency showed an 
altered glycan synthesis. It is worth noting that, glycosylation determines the proper function 
of several proteins involving in the developmental signaling pathways and the cell cycle [17, 
151]. Therefore, the disturbed glycosylation could lead to the catastrophe of the signaling 
pathways, which we could not see from the genomics level, and eventually resulted in the 
malformation of embryonic development in adpgk deficiency.  
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Figure 5.14 The dysregulation of N-glycosylation in adpgk deficiency. (A) Scheme of the 
glycomics study. (B) KD1 embryos showed decreased high mannose glycans with different 
charge. (C) The complex- and hybrid-type glycans were also decreased in the KD1 embryos.  
The glycan measurements and data analysis were done by Dr. Stefan Mittermayr and Dr. 
Sara Carillo at the NIBRT.  
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Table 5.6 Summary of the high mannose-type N-glycans 
 
m/z Charge Retention 
time (min) 
Anova 
(p) 
Max Fold 
Change 
Highest 
Mean 
Lowest 
Mean 
Maximum 
Abundance 
Name Name 
1029.386 1 4.713583 0.027056 0.903208 WT KD 232.6738 GlcNAc2Man3  
1353.491 1 10.09452 0.043886 0.926869 WT KD 8888.481 GlcNAc2Man5  
757.2658 2 13.22837 0.019844 0.932585 WT KD 10309 GlcNAc2Man6 
 
838.2919 2 16.0497 0.145742 0.956814 WT KD 6440.646 GlcNAc2Man7 
 
838.2927 2 16.5481 0.009447 0.882303 WT KD 12409.9 GlcNAc2Man7 
 
1839.645 1 19.17535 0.016774 0.90777 WT KD 1154.68 GlcNAc2Man8 
 
919.3165 2 19.19225 0.009371 0.902867 WT KD 20865.64 GlcNAc2Man7 
 
919.3156 2 19.5554 0.003392 0.878514 WT KD 17976.99 GlcNAc2Man8 
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1839.645 1 19.5554 0.015413 0.837473 WT KD 1330.272 GlcNAc2Man8 
 
2001.694 1 21.92905 0.001509 0.870389 WT KD 4362.468 GlcNAc2Man9 
 
1000.846 2 21.92905 0.037585 0.83812 WT KD 27657.2 GlcNAc2Man9 
 
1081.368 2 24.20127 0.069483 0.939776 WT KD 6323.053 GlcNAc3Hex9 
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Table 5.7 Summary of the complex- and hybris-type N-glycans 
 
m/z Charge Retention 
time (min) 
Anova 
(p) 
Max Fold 
Change 
Highest 
Mean 
Lowest 
Mean 
Maximum 
Abundance 
Name Structure 
777.7807 2 11.86833 0.889237 0.994286 WT KD 348.9237 GlcNAc3Hex5 
 
717.2674 2 7.898033 0.889017 0.990437 KD WT 125.4934 GlcNAc4Hex3 
 
1097.892 2 19.09082 0.56172 0.97768 WT KD 726.7034 GlcNAc4Hex5Fuc1NeuAc 
 
1340.975 2 27.44535 0.791328 0.949306 KD WT 102.461 GlcNAc4Hex7Fuc2NeuGc 
 
1097.889 2 18.67695 0.483568 0.939807 KD WT 133.3381 GlcNAc4Hex5Fuc1NeuAc1 
 
1332.969 2 25.8149 0.03413 0.893234 WT KD 1724.327 GlcNAc4Hex7Fuc2NeuAc 
 
1486.514 2 29.49777 0.001214 0.809614 WT KD 2478.518 GlcNAc4Hex6Fuc3NeuGc2 
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1032.859 2 19.5723 0.04534 0.792709 WT KD 387.7771 GlcNAc4Hex5NeuGc1 
 
1494.514 2 31.00988 0.000605 0.78321 WT KD 1728.907 GlcNAc4Hex7Fuc2NeuGc2 
 
1105.892 2 20.98297 0.105802 0.680286 WT KD 76.76036 GlcNAc4Hex5Fuc1NeuGc1 
 
 
 
GlcNAc4Hex6NeuAc 
 
 
858.8025 2 15.0867 0.08931 0.621453 WT KD 80.59007 GlcNAc3Hex6 
 
996.3373 3 30.99298 0.002938 0.171048 WT KD 36.40406 HexNAc4Hex7Fuc2NeuGc2 
 
 
 
DISCUSSION 
79 
 
6. DISCUSSION 
6.1 Adpgk fine tunes the glucose metabolism during embryonic development 
Our study is the first study characterizing the function of adpgk on the zebrafish embryonic 
development. Zebrafish embryos showed the highest adpgk expression at one cell stage; 
however, the expression started decreasing and remained at low levels afterwards. Unlike 
adpgk, the expression of hk1 was low during the very early embryonic development but hk1 
became the dominant hexokinase after the mid-blastrula stage. Consistent with our study, 
Rocha, F et al. have also reported the higher hk1 expression in the late zebrafish 
developmental stages [152]. Based on the low expression of adpgk, it seems that adpgk is not 
an important hexokinase post the maternal to zygotic transition. Despite adpgk not being the 
dominant hexokinase during the embryonic development. Knockdown of adpgk could 
significantly induce hk1 expression, suggesting the important role of adpgk in fine-tuning the 
glucose metabolism.  
The compensatory induction of hk1 strongly increased the glucose consumption, indicated by 
decreased free glucose and increased G6P. The adaptive glucose metabolism in adpgk 
deficiency showed increased glucose flux to the PPP but disturbed one-carbon metabolism 
and hexosamine biosynthesis pathways. The dysregulated N-glycans synthesis is proposed 
to further cause the malfunctions of proteins in developmental signaling pathways which led to 
the observed deformed convergent extension in adpgk deficient zebrafish embryos. 
In concert with the metabolic disturbance, adpgk knockdown embryonic cells endure an acid-
base imbalance and altered defense system against ROS. Furthermore, the metabolic stress 
induced the activation of cell cycle checkpoints [153] and apoptosis. Overall, the malfunction 
of the developmental signaling pathways and the increase of cell death eventually led to the 
crippled body patterning in adpgk deficient zebrafish. 
 
6.2 Adpgk knockdown disturbs glucose homeostasis and activates the PPP 
Adpgk knockdown embryos showed increased glucose consumption and glycolytic flux to the 
PPP, indicated by the decreased free glucose and increased G6P, Ru5P and GAP levels. High 
proliferative cells undergo aerobic glycolysis (Warburg phenotype) and activate PPP to provide 
precursors for the nucleotides synthesis [8]. However, the embryos with adpgk deficiency did 
not show increased lactate, the hallmark of aerobic glycolysis. Instead of performing aerobic 
glycolysis, the decreased lactate/pyruvate in adpgk knockdown embryos implied that the 
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embryonic cells employed the glucose metabolism through the TCA cycle for energy 
generation.  
According to our glycolytic flux study, knockdown of adpgk did not significantly alter the main 
glucose metabolism (glycolysis) and the energy generation but the PPP, one-carbon 
metabolism and hexosamine biosynthesis pathway. During early embryonic development, 
amino acids and fatty acids are the main energy resources and glucose is rather used in a 
biosynthetic role [152, 154]. Accordingly, the effect of adpgk on glycolysis and energy 
generation would not be prominent. The activated PPP can be observed in high proliferative 
cells due to the increased nucleotides synthesis [8]. However, the adpgk knockdown embryos 
were under cell cycle arrest and apoptosis. In addition, our preliminary result of the EdU 
staining indicated a rather decreased cell proliferation in ADPGK knockout Jurkat cells (data 
not shown). Besides, the activated PPP could also be a stress-response protecting cells from 
the ROS-induced damages. It has been shown that when cells are under a small level of stress, 
the activation of TIGAR (TP53-inducible glycolysis and apoptosis regulator) by p53 induces 
glucose-6-phsophate dehydrogenase (G6PD), the first enzyme in the PPP and deviates the 
glucose flux from glycolysis to the PPP to increase the production of antioxidants [155]. 
However, the activated PPP did not increase GSH/GSSG (antioxidants) in the adpgk 
knockdown embryos and cell death was increased. Thereby, it seemed that the activated PPP 
did not benefit the cells by either increasing the protection against ROS or supporting the cell 
proliferation.   
 
6.3 Adpgk knockdown decreases hexosamine biosynthesis and dysregulates 
glycoproteins of the developmental signaling pathways 
In addition to the increased G6P, Ru5P and GAP, the hexosamine biosynthesis pathway was 
dysregulated in the adpgk knockdown embryos. UDP-GlcNAc provides the building blocks for 
glycan synthesis and acts as a nutrient sensor by controlling the glycosylation of proteins 
involved in regulating glucose homeostasis [156, 157]. For instance, the decreased level of 
UDP-GlcNAc reduces the multiplicities of N-glycans. The glycans with low degree of branching, 
in turn, stabilize glycoproteins at the cell surface for increasing hexosamine concentration [158]. 
It has been shown that the levels of UDP-GlcNAc and Golgi N-acetylglucosaminyltransferases 
regulate the expression and function of glucagon receptor [157] and glucose transporters [159, 
160]. Therefore, in accompany with the decreased complex-type N-glycans in adpgk 
knockdown embryos, the increased G6P could also be a compensatory effect of cells 
attempting to increase hexosamine biosynthesis.   
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Many proteins involving in the developmental signaling pathways are glycoproteins [151]. 
During convergent extension and epithelial-mesenchymal transition in the embryonic 
development, the orchestration of different cell behaviors such as cell adhesion rearrangement, 
cytoskeletal reorganization and cellular polarity remodeling determine the embryonic body 
patterning [161-163].  
Adpgk knockdown embryos showed defective convergent extension during gastrulation and 
dysregulated Rac1/2/3 protein. Surprisingly, even though the developmental signaling 
pathways such as wnt, hh, notch, and bmp cross talk to one another [164-166], our results 
from the RT-qPCR screening did not reveal any significant changes of the main developmental 
signaling pathways in adpgk deficiency. Since wnt [167, 168], tgf-β receptor [169], notch 
receptor [170-172] and hh ligands [173] are glycoproteins bearing N-glycans, O-GlcNAc and/or 
O-glycans [151, 174] and adpgk knockdown embryos showed altered glycan patterning, we 
postulated that adpgk knockdown affects the posttranslational modification rather than the 
gene expression of the molecules involving in the developmental signaling pathways. The 
effect of adpgk on protein levels could also explain the insufficiency of dsh mRNA in rescuing 
the short body phenotype.  
Furthermore, the defect in developmental signaling pathway resulted in the disorganization of 
cell movement during convergent extension in the embryos with adpgk deficiency. The 
coordination of small GTPase Rac1/RacA and E-cadherin mediates the traction forces 
between cells and determines the cell motility [175]. It has been shown that E- and N-cadherin 
regulate the collective cell movement [176, 177] and knockdown of E-cadherin reduces the 
cell-cell adhesion and influences convergent extension during zebrafish gastrulation [178, 179]. 
Interestingly, Richter, S. et al. has indicated the decreased cadherins expression in ADPGK 
knockout H460 cells [55], which suggests the possible defect of cadherin in the embryos with 
adpgk deficiency and supports the disorganized cell movement observed in our study. 
 
6.4 Disturbed one-carbon metabolism in embryos with adpgk deficiency 
The targeted metabolic screening identified the decreased glycine, methionine and threonine, 
suggesting a disturbed one-carbon metabolism in the embryos with adpgk deficiency. One-
carbon metabolism generates the components essential for the synthesis of proteins, lipids 
and nucleotides, and the methylation modification [15, 180, 181]. Growing body of evidences 
have shown that the consumption of glycine and the mitochondrial expression of glycine 
biosynthetic enzymes as well as the activity of one carbon metabolism determine cancer cell 
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proliferation [13, 182, 183]. Therefore, the disturbed one-carbon metabolism in adpgk 
knockdown embryos indicates reduced cell proliferation.  
In addition, the growth of mouse embryonic stem cells shows a critical dependency on 
threonine [184]. Threonine or methionine deprivation reduces histone methylation and 
promotes cell death [184, 185]. Methionine deprivation down-regulates methylation, indicated 
by decreased SAM/SAH in vitro. Intriguingly, adpgk knockdown embryos showed decreased 
methionine but increased SAM/SHC, which seemed to be inconsistent that with the previous 
studies [186]. It could be possible that the consumption of methionine was higher, suggesting 
the increased methylation modification in adpgk deficiency [186]. Or it could be possible that 
the recycling of SAH to SAM was impaired due to the decreased threonine and glycine in 
regenerating SAM from SAH. Overall, the imbalanced production or consumption of threonine 
and methionine could lead to the dysregulation of methylation modification in adpgk deficiency, 
indicting the effect of adpgk on post translational modification.  
 
6.5 The imbalanced pH environment disturbs the cell behavior 
The results from the signal transduction PathwayFinder PCR array showed a significant 
decrease of ca9 expression in adpgk deficiency. The reduced ca9 expression could be rescued 
when co-injecting adpgk mRNA to adpgk deficient embryos, implying that the expression of 
ca9 and adpgk were highly correlated. Ca9 (EC 4.2.1.1) is a zinc metalloenzyme catalyzing 
the reversible hydration of carbon dioxide to bicarbonate and hydrogen ion. In response to the 
increased lactate production in cancer cells, ca9 is increased to facilitate the excretion of the 
intracellular lactate and CO2 [7, 8, 187], thereby, creating a “reversed” pH gradient with 
increased intracellular pH (pHi) and decreased extracellular pH (PHe). Studies have shown that 
high pHi inhibits apoptosis and induces glycolysis for cancer cell survival/proliferation while low 
pHe facilitates the damage of extracellular matrix and cell junction for cancer cell invasion [145, 
188].  
Accordingly, the strongly decreased ca9 expression in adpgk deficiency could imply a 
decreased pHi. The value of pHi less than 7.2 is a conserved characteristic of cells that undergo 
apoptosis [189, 190]. It addition, low pHi limits the activity of CDK1-cyclin B through the 
inhibitory phosphorylation of CDK1 and decreased expression of cyclin B [191]. Interestingly, 
in accordance with the decreased ca9 expression, the cdkn1a was activated in adpgk 
deficiency, which restricted the activity of CDK1-cyclin B and induced cell cycle arrest. 
Therefore, it seemed that adpgk knockdown embryos exhibited a pH environment prone for 
cell cycle arrest and cell death. 
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Moreover, pH status is important for cell migration. The expression of ca9 creates the correct 
pH cues with low pHe and high pHi at the moving cell front, and high pHe and low pHi at the cell 
rear [192-194]. In addition, Ca9 can also mediate the cell disassociation by regulating the 
binding of E-cadherin to β-catenin [192, 195]. It has been shown that suppressing Ca9 in 
HT1080 fibrosarcoma cells down-regulates the expression of small GTPase protein, MMP2, 
MMP9 and collegen IV [196, 197]. In accordance with the decreased ca9 expression, the level 
of Rac1/2/3 was significantly reduced, again suggesting the dysregulation of the cell 
adhesion/migration molecules in adpgk knockdown embryos.  
 
6.6 Knockdown of adpgk alters the defense system against ROS  
Knockdown of adpgk decreased the gene expression of anti-oxidant enzymes, nqo1 and 
txnrd1 and led to increased cell cycle arrest. Consistently, it has been reported that knockdown 
of nqo1 induces cdkn1a and reduces cyclin D1, which activates cell cycle arrest, and limits cell 
proliferation and migration in cholangiocarcinoma cells [198]. Besides, nqo1 participates in the 
first step (complex I) of OXPHOS. The decreased nqo1 suggested the possibility of impaired 
mitochondrial respiratory chain in adpgk deficiency. Previous study has shown that ADPGK 
knockout H460 cells exhibits compromised mitochondrial biogenesis, indicated by increased 
PPARGC1A (PGC-1α) and decreased OXPHOS complex I and II [55]; thus, leading to the 
depletion of mitochondrial membrane potential.  
Moreover, the metabolic changes reflected the alteration of defense system against ROS in 
adpgk deficiency. Glycine is the precursor of glutathione [199] and has been recognized as 
one of the main antioxidant molecule protecting cells against oxidative stress [200-202]. In 
accordance with the decreased glycine, the level of total glutathione was reduced in adpgk 
knockdown embryos. In addition to glycine, taurine scavenges ROS, alleviates lipid 
peroxidation and reduces apoptotic cells [203-205]. Taurine also acts as mitochondrial matrix 
buffer and the depletion of taurine is directly correlated to mitochondrial dysfunction [206]. 
Owing to the measurement of taurine in pooled embryos and keeping in mind the biological 
variations, a 1.4 fold decrease of taurine, could actually be meaningful in adpgk knockdown 
embryos. Overall, the increased glucose flux to PPP and the decreased anti-oxidant enzymes 
and molecules suggested a compromised defense system against ROS which could further 
alter the mitochondrial dysfunction and induce cell death in adpgk knockdown embryos. 
However, the level of oxidative stress in adpgk deficiency requires further studies for 
confirmation.  
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6.7 Adpgk deficiency induced apoptosis with an unknown mechanism 
The body phenotype correlated with the observed increased apoptosis in adpgk deficient 
embryos. In line with the increased apoptotic cells, indicated by Acridine Orange and TUNEL 
staining, adpgk knockdown showed increased pro-apoptotic factor, bbc3 and decreased anti-
apoptotic molecule, bcl2l. Studies have shown that akt2 modulates glucose availability and the 
downstream cell death pathways during zebrafish development [207-209]. It affects glucose 
uptake by regulating the expression of glucose transporters and induces glycolysis by 
stimulating the activity of hexokinase [208, 209]. In addition, akt is an antiapoptotic factor 
promoting cell survival by phosphorylating bad, a proapoptotic factor and further preventing 
the apoptosis by inhibiting the translocation of bax to mitochondria [207]. Our RT-qPCR results 
revealed, albeit the disturbed glucose homeostasis and increased apoptosis, unchanged akt 
and bad (data not shown) in the KD1 embryos, compared to the WT; indicating that adpgk 
deficiency did not trigger akt-mediated cell death.  
Moreover, p53 is the most common cell cycle and apoptosis regulator. When p53 is activated, 
it directly binds to the anti-apoptotic proteins (bcl-2 and bcl2l) and activates pro-apoptotic 
factors (bax and bak). The activation of bax and bak alters the permeabilization of 
mitochondrial outer membrane and further triggers apoptosis [210, 211]. Although our studies 
showed increased apoptosis in adpgk knockdown embryos, reducing p53 expression in adpgk 
deficient embryos could not rescue the phenotype. Instead, it increased the severity of 
phenotype and lethality.  
It seems that p53 is not activated or its expression remains unchanged or decreased in the 
embryos with adpgk deficiency. Interestingly, nqo1, in addition to its antioxidant activity, has 
been identified as a p53 stabilizer that can directly protect it from degradation [212]. The result 
of decreased nqo1 expression in the adpgk knockdown embryos supports the speculation of 
an unstable or decreased p53. Accordingly, it could be possible that knockdown of adpgk 
triggered a p53-independent apoptosis pathway.  
On the other hand, it could also be possible that adpgk knockdown embryos did show activated 
p53 and the activated p53 is protective for the cells. P53 induces cell cycle arrest by directly 
binding to the cell cycle checkpoint molecules such as cdkn1a and gadd45aa [213], allowing 
cells to repair the damage. The activation of cdkn1a can protect cells against apoptosis [214]. 
In this case, supposing that the suppression of p53 by morpholino also reduced cdkn1a 
expression in adpgk knockdown embryos, the exacerbation outcome observed could be 
explained. Therefore, the activated cell cycle checkpoints in the embryos with adpgk deficiency 
could be a compensatory effect of cells attempting to repair the damages and/or the metabolic 
stress [142]. However, the role of cdkn1a in apoptosis has been conflicting. Depends on the 
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stimuli, cdkn1a can inhibit or promote apoptosis [214, 215]. It remains puzzling whether cdkn1a 
acts as an anti-apoptotic or pro-apoptotic factor in adpgk knockdown embryos.  
Besides p53, cdkn1a can be regulated by the signals generating from growth factors and 
GTPase Rho-mediated Ras. Epidermal growth factor or interferon-γ activates cdkn1a by 
triggering the targeting of stat1 to cdkn1a [216]. On the other hand, the activation of cdkn1a 
can be suppressed by GTPase Rho-mediated Ras induction [217]. Given the decreased 
GTPase protein, rac1/2/3 in adpgk deficiency, we attempted to investigate whether ras and/or 
stat1 were involved in activating cdkn1a. However, the expression of ras and stat1 remained 
unchanged in the KD1 embryos (data not shown). Therefore, mechanism of the cdkn1a 
activation and its role in apoptosis merit further investigation.  
 
6.8 Disturbed N-glycan synthesis affects the embryonic development  
Glycosylation is important in determining the proper protein functions. There are several 
studies regarding the gene regulation of glycosylation; however, the understanding and 
research of glycan structures in zebrafish are scarce [151]. 
We extracted glycans from 200 zebrafish embryos at 22 hpf and performed glycomics study. 
The results showed a general decrease of high mannose type-glycans in adpgk knockdown 
embryos; however, the fold change was not very prominent. It is known that the yolk contains 
high amounts of nutrients such as phospholipoglycoproteins for supporting embryonic 
development [218, 219]. The high amount glycoproteins present in the yolk [220] can mask the 
actual change of glycans in the embryos; thus, the effect of adpgk knockdown on decreasing 
glycan synthesis were actually underestimated in our study.  
Our glycomic analysis identified several complex- and hybrid-type glycans in the zebrafish 
embryos at 22 hpf. Consistent with our findings, previous studies also have reported the same 
complex- and hybrid-type glycans expressed in the zebrafish embryos [219, 221] and found 
the high expression of the atypical complex-glycans during the embryonic segmentation stage 
[221]. It has been indicated that the structures and patterns of glycans are very diverse and 
stage-specific during the embryogenesis [151].  
Adpgk knockdown embryos showed a 1.6 fold decrease of glycans bearing β1,4-linkage of 
galactose to GlcNAc (GlcNAc2Man5GlcNAcGal). This type of β1,4-linkage is formed by β1,4-
galactosyltransferase (beta4GalT). Interestingly, beta4GalT knockdown zebrafish embryos 
show aberrant convergent extension, which is consistent with our study [222].  
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In addition to N-glycosylation, the O-GlcNAc blot revealed the changes of protein O-
GlcNAcylation in adpgk knockdown embryos. O-GlcNAc transferase (OGT) and O-GlcNAcase 
(OGA) catalyzes the attachment and removal of O-GlcNac on proteins, respectively [32]. 
Overexpression of OGT or OGT in zebrafish embryos showed cytoskeletal disorganization, 
short body axis, small brain and increased cell death [223], which are similar to the adpgk 
knockdown embryos. Moreover, O-GlcNAcylation is highly correlated with phosphorylation 
[224]. Wang, Z. et al. has reported that inhibiting a single kinase, GSK3β, can increase the O-
GlcNAcylation of cytoskeletal and heat shock proteins, and decrease the O-GlcNAcylation of 
transcription factors and RNA-binding proteins [225]. Thus, knockdown of adpgk could directly 
link to the altered protein O-GlcNAcylation. Due to the extensive crosstalk between O-
GlcNAcylation and phosphorylation, the altered O-GlcNAcylation in adpgk knockdown 
embryos possibly disturbs the protein phosphorylation, which affects the protein function in 
very diverse ways.   
Overall, we revealed the altered glycosylation in adpgk knockdown embryos. The dysregulated 
protein and lipid glycosylation are the features of congenital disorders of glycosylation (CDG) 
[226]. CDG is resulted from the malfunctioning of enzymes or proteins involved in regulating 
glycan synthesis, Golgi architecture, vesicular trafficking and pH [227]. Patients with CDG 
show wide range of symptoms including neurological defects, muscular dystrophy, 
cardiomyopathy, retinal degeneration, anemia, and enteropathy as well as growth retardation 
[226, 228]. Knockdown of adpgk also showed various phenotypes including deformed eyes, 
short body axis, dysregulated somitogenesis and deformed cardiovascular system in the 
zebrafish embryos. Therefore, adpgk deficiency could be linked to a novel type of CDG.   
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7. CONCLUSION 
We successfully established the morpholino-mediated loss-of-function zebrafish model and 
observed the phenotypes of defective convergent extension movement and short/dorsalized 
body axis. Knockdown of adpgk disturbed glucose metabolism with activated pentose 
phosphate pathway, exhibiting a reduction in one-carbon metabolism and hexosamine 
biosynthesis pathway. The dysregulated N-glycans synthesis caused the malfunctioning of 
proteins in the developmental signaling pathways which led to deformed embryonic body 
patterning in zebrafish. Overall, adpgk acts as a key regulator of glucose metabolism during 
the early stages of embryonic development in zebrafish. 
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